52 results on '"Corbett, Elizabeth L."'
Search Results
2. Should all adults with symptoms of tuberculosis be offered HIV testing? A systematic 1 literature review and meta-analysis
- Author
-
Marriott Nliwasa, Macpherson, Peter, Madalo Mukoka, Satvinder Singh, Baddeley, Baggaley, Rachel, Jamil, Muhammad S, Johnson, Cheryl, and Corbett, Elizabeth L
- Published
- 2022
- Full Text
- View/download PDF
3. Incidence of HIV-positive admission and inpatient mortality in Malawi [2012-2019]: a population cohort study
- Author
-
Burke, Rachael M, Henrion, Marc, Mallewa, Jane, Masamba, Leo, Kalua, Thokozani, Khundi, McEwan, Gupta-Wright, Ankur, Rylance, Jamie, Gordon, Stephen, Masesa, Clemens, Corbett, Elizabeth L, Mwandumba, Henry, and MacPherson, Peter
- Subjects
wx_173 ,wa_395 ,wc_503 ,d67ea616 - Abstract
OBJECTIVE\ud \ud To investigate trends in population incidence of HIV positive hospital admission and risk of in-hospital death among adults living with HIV between 2012 and 2019 in Blantyre, Malawi.\ud \ud DESIGN\ud \ud Population cohort study using an existing electronic health information system ('SPINE') at Queen Elizabeth Central Hospital and Blantyre census data.\ud \ud METHODS\ud \ud We used multiple imputation and negative binomial regression to estimate population age- and sex-specific admission rates over time. We used a log-binomial model to investigate trends in risk of in-hospital death.\ud \ud RESULTS\ud \ud Of 32,814 adult medical admissions during Q4.2012-Q3.2019, HIV status was recorded for 75.6%. HIV-positive admissions decreased substantially between 2012 and 2019. After imputation for missing data, HIV positive admissions were highest in Q3.2013 (173 per 100,000 adult Blantyre residents) and lowest in Q3.2019 (53 per 100,000 residents). An estimated 10,818 fewer than expected people living with HIV (PLHIV) (95%CI 10,068-11,568) were admitted during 2012-2019 compared to the counterfactual situation where admission rates stayed the same throughout this period. Absolute reductions were greatest for women aged 25-34 years (2,264 fewer HIV-positive admissions, 95%CI 2,002-2,526). In-hospital mortality for PLHIV was 23.5%, with no significant change over time in any age-sex group, and no association with ART use at admission.\ud \ud CONCLUSIONS\ud \ud Rates of admission for adult PLHIV decreased substantially, likely due to large increases in community provision of HIV diagnosis, treatment and care. However, HIV-positive in-hospital deaths remain unacceptably high, despite improvements in ART coverage. A concerted research and implementation agenda is urgently needed to reduce inpatient deaths among PLHIV.
- Published
- 2021
4. Pattern of Abnormalities amongst Chest X‐rays of Adults Undergoing Computer‐Assisted Digital Chest X‐Ray Screening for Tuberculosis in Peri‐Urban Blantyre, Malawi: A Cross‐Sectional Study
- Author
-
Twabi, Hussein H, Semphere, Robina, Mukoka, Madalo, Chiume, Lingstone, Nzawa, Rebecca, R A Feasey, Helena, Lipenga, Trancizeo, MacPherson, Peter, Corbett, Elizabeth L, and Nliwasa, Marriott
- Subjects
wf_220 ,wa_395 ,wf_200 ,wf_225 - Abstract
Background\ud The prevalence of diseases other than tuberculosis (TB) detected during chest x-ray screening is poorly described in sub-Saharan Africa. Computer-assisted digital chest x-ray technology is available for TB screening and has potential to be a screening tool for non-communicable diseases as well. Low- and middle-income countries are in a transition period where the burden of noncommunicable diseases is increasing but health systems are mainly focused on addressing infectious diseases.\ud \ud Methods\ud Participants were adults undergoing computer-assisted chest x-ray screening for tuberculosis in a community-wide tuberculosis prevalence survey in Blantyre, Malawi. Adults with abnormal radiographs by Field Radiographer interpretation were evaluated by a physician in a community-based clinic. X-ray classifications were compared to classifications of a random sample of normal chest x-rays by radiographer interpretation. Radiographic features were classified using WHO Integrated Management for Adult Illnesses (IMAI) guidelines. All radiographs taken at the screening tent were analysed by the Qure.ai qXR v2.0 software.\ud \ud Results\ud 5% (648/13,490) of adults who underwent chest radiography were identified to have an abnormal chest x-ray by the radiographer. 387 (59.7%) of the participants attended the x-ray clinic and another 387 randomly sampled normal x-rays were available for comparison. Participants who were referred to the community clinic had a significantly higher HIV prevalence than those who had been identified to have a normal CXR by the field radiographer (90 [23.3%] versus 43 [11.1%] p-value
- Published
- 2021
5. Pattern of abnormalities amongst chest X-rays of adults undergoing computer-assisted digital chest X-ray screening for tuberculosis in Peri-Urban Blantyre, Malawi: A cross-sectional study
- Author
-
Twabi, Hussein H, Semphere, Robina, Mukoka, Madalo, Chiume, Lingstone, Nzawa, Rebecca, Feasey, Helena RA, Lipenga, Trancizeo, MacPherson, Peter, Corbett, Elizabeth L, and Nliwasa, Marriott
- Abstract
BACKGROUND: The prevalence of diseases other than tuberculosis (TB) detected during chest X-ray screening is poorly described in sub-Saharan Africa. Computer-assisted digital chest X-ray technology is available for TB screening and has the potential to be a screening tool for non-communicable diseases as well. Low- and middle-income countries are in a transition period where the burden of non-communicable diseases is increasing, but health systems are mainly focused on addressing infectious diseases. METHODS: Participants were adults undergoing computer-assisted chest X-ray screening for tuberculosis in a community-wide tuberculosis prevalence survey in Blantyre, Malawi. Adults with abnormal radiographs by field radiographer interpretation were evaluated by a physician in a community-based clinic. X-ray classifications were compared to classifications of a random sample of normal chest X-rays by radiographer interpretation. Radiographic features were classified using WHO Integrated Management for Adult Illnesses (IMAI) guidelines. All radiographs taken at the screening tent were analysed by the Qure.ai qXR v2.0 software. RESULTS: 5% (648/13,490) of adults who underwent chest radiography were identified to have an abnormal chest X-ray by the radiographer. 387 (59.7%) of the participants attended the X-ray clinic, and another 387 randomly sampled normal X-rays were available for comparison. Participants who were referred to the community clinic had a significantly higher HIV prevalence than those who had been identified to have a normal CXR by the field radiographer (90 [23.3%] vs. 43 [11.1%] p-value < 0.001). The commonest radiographic finding was cardiomegaly (20.7%, 95% CI 18.0-23.7). One in five (81/387) chest X-rays were misclassified by the radiographer. The overall mean Qure.ai qXR v2.0 score for all reviewed X-rays was 0.23 (SD 0.20). There was a high concordance of cardiomegaly classification between the physician and the computer-assisted software (109/118, 92.4%). CONCLUSION: There is a high burden of cardiomegaly on a chest X-ray at a community level, much of which is in patients with diabetes, heart disease and high blood pressure. Cardiomegaly on chest X-ray may be a potential tool for screening for cardiovascular NCDs at the primary care level as well as in the community.
- Published
- 2021
6. Economic costs of accessing tuberculosis (TB) diagnostic services in Malawi: an analysis of patient costs from a randomised controlled trial of computer-aided chest x-ray interpretation
- Author
-
Kamchedzera, Wala, Maheswaran, Hendramoorthy, Squire, S Bertie, Joekes, Elizabeth, Pai, Madhukar, Nliwasa, Marriott, G Lalloo, David, Webb, Emily L, Corbett, Elizabeth L, and MacPherson, Peter
- Subjects
wf_220 ,wn_180 ,wa_395 ,wf_200 ,41b6e438 ,health care economics and organizations - Abstract
Background: Patients with tuberculosis (TB) symptoms in low-resource settings face convoluted diagnostic and treatment linkage pathways, incurring substantial health-seeking costs. In the context of a randomised trial looking at the impact of novel diagnostics such as computer-aided chest x-ray diagnosis (CAD4TB), we aimed to investigate the costs incurred by patients seeking TB diagnosis and whether optimised diagnostic interventions could result in a reduction in the cost faced by households. Methods: PROSPECT was a three-arm randomised trial conducted in a public primary health clinic in Blantyre, Malawi during 2018-2019 (trial arms: standard of care [SOC]; HIV testing [HIV]; HIV testing and CAD4TB [HIV/TB]). The direct and indirect costs incurred by 219 PROSPECT participants over the 56-day follow-up period were collected. Costs were deemed catastrophic if they exceeded 20% of annual household income. We compared mean costs and used generalised linear regression models to examine whether the interventions could result in a reduction in total costs. Results: The mean total cost incurred by all 219 participants was US$12.11 (standard error (SE): 1.86). The indirect and direct cost was US$8.47 (SE: 1.66) and US$3.64 (SE: 0.38), respectively. The mean total cost composed of 5.6% of the average annual household income. In total, 5% (9/180) of the participants with complete income data \ud Open Peer Review\ud Reviewer Status AWAITING PEER REVIEW Any reports and responses or comments on the article can be found at the end of the article.\ud Page 1 of 13\ud Wellcome Open Research 2021, 6:153 Last updated: 02 JUL 2021\ud Corresponding author: Wala Kamchedzera (wala.kamchedzera@gmail.com) Author roles: Kamchedzera W: Conceptualization, Data Curation, Formal Analysis, Investigation, Methodology, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing; Maheswaran H: Conceptualization, Methodology, Supervision, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing; Squire SB: Visualization, Writing – Original Draft Preparation, Writing – Review & Editing; Joekes E: Visualization, Writing – Original Draft Preparation, Writing – Review & Editing; Pai M: Visualization, Writing – Original Draft Preparation, Writing – Review & Editing; Nliwasa M: Visualization, Writing – Original Draft Preparation, Writing – Review & Editing; G Lalloo D: Visualization, Writing – Original Draft Preparation, Writing – Review & Editing; Webb EL: Visualization, Writing – Original Draft Preparation, Writing – Review & Editing; Corbett EL: Visualization, Writing – Original Draft Preparation, Writing – Review & Editing; MacPherson P: Conceptualization, Funding Acquisition, Methodology, Supervision, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing Competing interests: No competing interests were disclosed. Grant information: PM was supported by the Wellcome Trust (grant number: WT206575). WK was supported by Wellcome (grant number: 218333/Z/19/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Copyright: © 2021 Kamchedzera W et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Data associated with the article are available under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original data is properly cited. How to cite this article: Kamchedzera W, Maheswaran H, Squire SB et al. Economic costs of accessing tuberculosis (TB) diagnostic services in Malawi: an analysis of patient costs from a randomised controlled trial of computer-aided chest x-ray interpretation [version 1; peer review: awaiting peer review] Wellcome Open Research 2021, 6:153 https://doi.org/10.12688/wellcomeopenres.16683.1 First published: 15 Jun 2021, 6:153 https://doi.org/10.12688/wellcomeopenres.16683.1 \ud incurred catastrophic costs. Compared to SOC, there was no statistically significant difference in the mean total cost faced by those in the HIV (ratio: 0.77, 95% CI: 0.51, 1.19) and HIV/TB arms (ratio: 0.85, 95% CI: 0.53, 1.37). Conclusions: Despite the absence of user fees, patients seeking healthcare with TB symptoms incurred catastrophic costs. The optimised TB diagnostic interventions that were investigated in the PROSPECT study did not significantly reduce costs. TB diagnosis interventions should be implemented alongside social protection policies whilst ensuring healthcare facilities are accessible by the poor
- Published
- 2021
7. Impact of COVID-19 on tuberculosis notifications in Blantyre Malawi: an interrupted time series analysis and qualitative study with healthcare workers
- Author
-
Soko, Rebecca Nzawa, Burke, Rachael M, Feasey, Helena RA, Sibande, Wakumanya, Nliwasa, Marriott, Henrion, Marc YR, Khundi, McEwen, Dodd, Peter J, Ku, Chu Chang, Kawalazira, Gift, Choko, Augustine T, Divala, Titus H, Corbett, Elizabeth L, and MacPherson, Peter
- Abstract
COVID-19 may impact on tuberculosis (TB) diagnosis and care. We analysed a city-wide electronic TB register in Blantyre, Malawi and interviewed TB officers. Malawi had no official “lockdown” but closed schools and borders on 23 March 2020. In interrupted time series analysis, there was an immediate 35.9% reduction in TB notifications (95% CI 22.0 to 47.3%) in April, which recovered to near pre-pandemic numbers by December 2020, but with 333 (95% CI 291 to 375) fewer cumulative notifications than anticipated. Women and girls were impacted (30.7% fewer cases, 95% CI 28.4 to 33.0%) more than men and boys (20.9% fewer, 95% CI 18.5 to 23.3). Fear of COVID-19 infection, temporary facility closure, inadequate protective equipment and COVID-19 stigma with similar presenting symptoms to TB were mentioned. Public health measures could benefit both TB and COVID-19, but only if diagnostic services remain accessible and are considered safe to attend.
- Published
- 2021
8. Non-Tuberculous Mycobacterial Pulmonary Disease identified during community-based screening for Mycobacterium Tuberculosis: a case report
- Author
-
Twabi, Hussein H, Mukoka-Thindwa, Madalo, Shani, Doris, Nliwasa, Marriott, and Corbett, Elizabeth L
- Subjects
Mycobacterium avium complex ,Non-Tuberculous mycobacteria ,screening ,Case Report ,bacterial infections and mycoses - Abstract
There is a rising prevalence of Non-Tuberculous Mycobacterial (NTM) disease in sub-Saharan Africa identified on culture specimens. However, distinguishing mycobacterial colonisations from infection from identified NTMs on culture in the sub-Saharan Africa setting remains to be established. A 49-year-old man presented with the cardinal symptoms of tuberculosis (TB) in a community TB prevalence survey in Blantyre, Malawi. Mycobacteriology was atypical, prompting a line probe assay which revealed Mycobacterium avium complex (MAC) species. The epidemiology of Mycobacterium tuberculosis complex (MTBC) is better known than that of NTM. Up-scaling culture and speciation may be a solution to this gap in knowledge of the burden of disease of NTM. Like most resource-poor settings, TB culture is not routinely done in the diagnosis and management of TB in Malawi. Furthermore, the treatment of NTM is not analogous to that of MTBC. The multi-drug regimens used for NTM disease treatment includes a newer macrolide (azithromycin, clarithromycin), ethambutol, and rifamycin, and require prolonged durations of therapy aimed at facilitating clearance of the mycobacteria and minimizing the emergence of drug resistance. Clinicians must thus be aware of this rising burden of NTM disease and consider other diagnostic options to better investigate this disease in patients.
- Published
- 2021
9. Additional file 1 of Durations of asymptomatic, symptomatic, and care-seeking phases of tuberculosis disease with a Bayesian analysis of prevalence survey and notification data
- Author
-
Ku, Chu-Chang, MacPherson, Peter, Khundi, McEwen, Nzawa Soko, Rebecca H., Feasey, Helena R. A., Nliwasa, Marriott, Horton, Katherine C., Corbett, Elizabeth L., and Dodd, Peter J.
- Abstract
Additional file 1. Supplementary materials including: Sources of data; Model details; Inference on delay and duration, posterior distribution by country sensitivity analysis
- Published
- 2021
- Full Text
- View/download PDF
10. Additional file 1 of ‘Too old to test?’: A life course approach to HIV-related risk and self-testing among midlife-older adults in Malawi
- Author
-
Johnson, Cheryl, Kumwenda, Moses, Meghji, Jamilah, Choko, Augustine T., Mackwellings Phiri, Hatzold, Karin, Baggaley, Rachel, Taegtmeyer, Miriam, Terris-Prestholt, Fern, Desmond, Nicola, and Corbett, Elizabeth L.
- Abstract
Additional file 1: Table S1. Detailed summary of participant quotes from focus group discussions and in-depth interviews across the life course.
- Published
- 2021
- Full Text
- View/download PDF
11. Effect of Once-Weekly Azithromycin vs Placebo in Children With HIV-Associated Chronic Lung Disease: The BREATHE Randomized Clinical Trial
- Author
-
Ferrand, Rashida A, McHugh, Grace, Rehman, Andrea M, Mujuru, Hilda, Simms, Victoria, Majonga, Edith D, Nicol, Mark P, Flaegstad, Trond, Gutteberg, Tore J, Gonzalez-Martinez, Carmen, Corbett, Elizabeth L, Rowland-Jones, Sarah L, Kranzer, Katharina, Weiss, Helen A, Odland, Jon O, and BREATHE Trial Group
- Abstract
Importance: HIV-associated chronic lung disease (HCLD) in children is associated with small airways disease, is common despite antiretroviral therapy (ART), and is associated with substantial morbidity. Azithromycin has antibiotic and immunomodulatory activity and may be effective in treating HCLD through reducing respiratory tract infections and inflammation. Objective: To determine whether prophylactic azithromycin is effective in preventing worsening of lung function and in reducing acute respiratory exacerbations (AREs) in children with HCLD taking ART. Design, Setting, and Participants: This double-blind, placebo-controlled, randomized clinical trial (BREATHE) was conducted between 2016 and 2019, including 12 months of follow-up, at outpatient HIV clinics in 2 public sector hospitals in Malawi and Zimbabwe. Participants were randomized 1:1 to intervention or placebo, and participants and study personnel were blinded to treatment allocation. Participants included children aged 6 to 19 years with perinatally acquired HIV and HCLD (defined as forced expiratory volume in 1 second [FEV1] z score < -1) who were taking ART for 6 months or longer. Data analysis was performed from September 2019 to April 2020. Intervention: Once-weekly oral azithromycin with weight-based dosing, for 48 weeks. Main Outcomes and Measures: All outcomes were prespecified. The primary outcome was the mean difference in FEV1 z score using intention-to-treat analysis for participants seen at end line. Secondary outcomes included AREs, all-cause hospitalizations, mortality, and weight-for-age z score. Results: A total of 347 individuals (median [interquartile range] age, 15.3 [12.7-17.7] years; 177 boys [51.0%]) were randomized, 174 to the azithromycin group and 173 to the placebo group; 162 participants in the azithromycin group and 146 placebo group participants had a primary outcome available and were analyzed. The mean difference in FEV1 z score was 0.06 (95% CI, -0.10 to 0.21; P = .48) higher in the azithromycin group than in the placebo group, a nonsignificant difference. The rate of AREs was 12.1 events per 100 person-years in the azithromycin group and 24.7 events per 100 person-years in the placebo groups (hazard ratio, 0.50; 95% CI, 0.27 to 0.93; P = .03). The hospitalization rate was 1.3 events per 100 person-years in the azithromycin group and 7.1 events per 100 person-years in the placebo groups, but the difference was not significant (hazard ratio, 0.24; 95% CI, 0.06 to 1.07; P = .06). Three deaths occurred, all in the placebo group. The mean weight-for-age z score was 0.03 (95% CI, -0.08 to 0.14; P = .56) higher in the azithromycin group than in the placebo group, although the difference was not significant. There were no drug-related severe adverse events. Conclusions and Relevance: In this randomized clinical trial specifically addressing childhood HCLD, once-weekly azithromycin did not improve lung function or growth but was associated with reduced AREs; the number of hospitalizations was also lower in the azithromycin group but the difference was not significant. Future research should identify patient groups who would benefit most from this intervention and optimum treatment length, to maximize benefits while reducing the risk of antimicrobial resistance. Trial Registration: ClinicalTrials.gov Identifier: NCT02426112.
- Published
- 2020
12. Longitudinal PKPD biomarkers correlate with treatment outcome in drug sensitive pulmonary tuberculosis; a population pharmacokinetic-pharmacodynamic analysis
- Author
-
Kloprogge, Frank, Mwandumba, Henry C., Kamdolozi, Mercy, Banda, Gertrude, Shani, Doris, Corbett, Elizabeth L., Kontogianni, Nadia, Ward, Steve, Khoo, Saye H., Davies, Geraint R., Sloan, Derek James, University of St Andrews. School of Medicine, and University of St Andrews. Infection and Global Health Division
- Subjects
RM ,qw_541 ,NDAS ,qv_38 ,RM Therapeutics. Pharmacology ,Pharmacodynamics ,Standard treatment ,SDG 3 - Good Health and Well-being ,qv_268 ,RC Internal medicine ,Tuberculosis ,Pharmacokinetics ,wf_200 ,qy_120 ,Outcome ,RC - Abstract
Funding: Wellcome Trust Clinical PhD Fellowship awarded to D.S. (086757/Z/08/A). Funding for the minimum inhibitory concentration assays was provided by a grant from the British Society for Antimicrobial Chemotherapy (GA2015_036P). F.K. has conducted the research as part of his Medical Research Council fellowship (MR/P014534/1). Background . This study aims to explore relationships between baseline demographic covariates, plasma antibiotic exposure, sputum bacillary load, and clinical outcome data to help improve future tuberculosis (TB) treatment response predictions. Methods . Data were available from a longitudinal cohort study in Malawian drug-sensitive TB patients on standard therapy, including steady-state plasma antibiotic exposure (154 patients), sputum bacillary load (102 patients), final outcome (95 patients), and clinical details. Population pharmacokinetic and pharmacokinetic-pharmacodynamic models were developed in the software package NONMEM. Outcome data were analyzed using univariate logistic regression and Cox proportional hazard models in R, a free software for statistical computing. Results . Higher isoniazid exposure correlated with increased bacillary killing in sputum (P
- Published
- 2020
13. Who is Reached by HIV Self-Testing? Individual Factors Associated With Self-Testing Within a Community-Based Program in Rural Malawi
- Author
-
Indravudh, Pitchaya P, Hensen, Bernadette, Nzawa, Rebecca, Chilongosi, Richard, Nyirenda, Rose, Johnson, Cheryl C, Hatzold, Karin, Fielding, Katherine, Corbett, Elizabeth L, and Neuman, Melissa
- Abstract
INTRODUCTION: HIV self-testing (HIVST) is an alternative strategy for reaching population subgroups underserved by available HIV testing services. We assessed individual factors associated with ever HIVST within a community-based program. SETTING: Malawi. METHODS: We conducted secondary analysis of an end line survey administered under a cluster-randomized trial of community-based distribution of HIVST kits. We estimated prevalence differences and prevalence ratios (PRs) stratified by sex for the outcome: self-reported ever HIVST. RESULTS: Prevalence of ever HIVST was 45.0% (475/1055) among men and 40.1% (584/1456) among women. Age was associated with ever HIVST in both men and women, with evidence of a strong declining trend across categories of age. Compared with adults aged 25-39 years, HIVST was lowest among adults aged 40 years and older for both men [34.4%, 121/352; PR 0.74, 95% confidence interval (CI): 0.62 to 0.88] and women (30.0%, 136/454; PR 0.71, 95% CI: 0.6 to 0.84). Women who were married, had children, had higher levels of education, or were wealthier were more likely to self-test. Men who had condomless sex in the past 3 months (47.9%, 279/582) reported a higher HIVST prevalence compared with men who did not have recent condomless sex (43.1%, 94/218; adjusted PR 1.37, 95% CI: 1.06 to 1.76). Among men and women, the level of previous exposure to HIV testing and household HIVST uptake was associated with HIVST. CONCLUSIONS: Community-based HIVST reached men, younger age groups, and some at-risk individuals. HIVST was lowest among older adults and individuals with less previous exposure to HIV testing, suggesting the presence of ongoing barriers to HIV testing.
- Published
- 2020
14. Patient‐incurred cost of inpatient treatment for Tuberculosis in rural Malawi
- Author
-
Shin, Hyejeong, Ngwira, Lucky-Gift, Tucker, Austin, Chaisson, Richard E., Corbett, Elizabeth L., and Dowdy, David W.
- Subjects
wa_395 ,wf_200 ,wf_310 ,41b6e438 ,health care economics and organizations - Abstract
Objectives: To mitigate the economic burden of tuberculosis (TB), it is important to fully understand the costs of TB treatment from the patient perspective. We therefore sought to quantify the patient-incurred cost of TB treatment in rural Malawi, with specific focus on costs borne by patients requiring inpatient hospitalization.
- Published
- 2020
15. Systematic Review and Meta-Analysis of Sex Differences in Social Contact Patterns and Implications for Tuberculosis Transmission and Control
- Author
-
Horton, Katherine C, Hoey, Anne L, Béraud, Guillaume, Corbett, Elizabeth L, and White, Richard G
- Abstract
Social contact patterns might contribute to excess burden of tuberculosis in men. We conducted a study of social contact surveys to evaluate contact patterns relevant to tuberculosis transmission. Available data describe 21 surveys in 17 countries and show profound differences in sex-based and age-based patterns of contact. Adults reported more adult contacts than children. Children preferentially mixed with women in all surveys (median sex assortativity 58%, interquartile range [IQR] 57%-59% for boys, 61% [IQR 60%-63%] for girls). Men and women reported sex-assortative mixing in 80% and 95% of surveys (median sex assortativity 56% [IQR 54%-58%] for men, 59% [IQR 57%-63%] for women). Sex-specific patterns of contact with adults were similar at home and outside the home for children; adults reported greater sex assortativity outside the home in most surveys. Sex assortativity in adult contacts likely contributes to sex disparities in adult tuberculosis burden by amplifying incidence among men.
- Published
- 2020
16. Additional file 3 of Use and awareness of and willingness to self-test for HIV: an analysis of cross-sectional population-based surveys in Malawi and Zimbabwe
- Author
-
Johnson, Cheryl, Neuman, Melissa, MacPherson, Peter, Choko, Augustine, Quinn, Caitlin, Wong, Vincent J., Hatzold, Karin, Nyrienda, Rose, Getrude Ncube, Baggaley, Rachel, Terris-Prestholt, Fern, and Corbett, Elizabeth L.
- Abstract
Additional File 3: Table S3. Univariable and multivariable associations between sociodemographic factors and willingness to self-test among men in Zimbabwe, by testing history, 2015–16. Supplementary data with univariable and multivariable associations between sociodemographic factors and willingness to self-test among men in Zimbabwe
- Published
- 2020
- Full Text
- View/download PDF
17. Systematic Review and Meta-Analysis of Sex Differences in Social Contact Patterns and Implications for Tuberculosis Transmission and Control
- Author
-
Horton, Katherine C., Hoey, Anne L., BERAUD, Guillaume, Corbett, Elizabeth L., White, Richard G., Hoey, Anne/0000-0003-0164-3959, and Beraud, Guillaume/0000-0002-4705-0916
- Subjects
Mycobacterium-Tuberculosis ,Spread ,Prevalence ,Gender ,Community - Abstract
Social contact patterns might contribute to excess burden of tuberculosis in men. We conducted a study of social contact surveys to evaluate contact patterns relevant to tuberculosis transmission. Available data describe 21 surveys in 17 countries and show profound differences in sex-based and age-based patterns of contact. Adults reported more adult contacts than children. Children preferentially mixed with women in all surveys (median sex assortativity 58%, interquartile range [IQR] 57%-59% for boys, 61% [IQR 60%-63%] for girls). Men and women reported sex-assortative mixing in 80% and 95% of surveys (median sex assortativity 56% [IQR 54%-58%] for men, 59% [IQR 57%-63%] for women). Sex-specific patterns of contact with adults were similar at home and outside the home for children; adults reported greater sex assortativity outside the home in most surveys. Sex assortativity in adult contacts likely contributes to sex disparities in adult tuberculosis burden by amplifying incidence among men. E.L.C. was supported by a Wellcome Trust Senior Research Fellowship in Clinical Science (WT091769). R.G.W. was supported the UK Medical Research Council and the UK Department for International Development under the Medical Research Council/Department for International Development Concordat agreement that is also part of the European and Developing Countries Clinical Trials Partnership 2 Programme supported by the European Union (MR/P002404/1); and the Bill and Melinda Gates Foundation (TB Modelling and Analysis Consortium: OPP1084276/OPP1135288, SA Modelling for Policy: OPP1110334, CORTIS: OPP1137034, Vaccines: OPP1160830) and UNITAID (4214-LSHTM-Sept15; PO 8477-0-600). Horton, KC (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England. katherine.horton@lshtm.ac.uk
- Published
- 2020
18. Additional file 2 of Use and awareness of and willingness to self-test for HIV: an analysis of cross-sectional population-based surveys in Malawi and Zimbabwe
- Author
-
Johnson, Cheryl, Neuman, Melissa, MacPherson, Peter, Choko, Augustine, Quinn, Caitlin, Wong, Vincent J., Hatzold, Karin, Nyrienda, Rose, Getrude Ncube, Baggaley, Rachel, Terris-Prestholt, Fern, and Corbett, Elizabeth L.
- Abstract
Additional File 2: Table S2. Univariable and multivariable associations between sociodemographic factors and ever-self-testing for HIV in Malawi and Zimbabwe, 2015–16. Supplementary data with univariable and multivariable associations between sociodemographic factors and ever-self-testing for HIV in Malawi and Zimbabwe
- Published
- 2020
- Full Text
- View/download PDF
19. Investigating interventions to increase uptake of HIV testing and linkage into care or prevention for male partners of pregnant women in antenatal clinics in Blantyre, Malawi: study protocol for a cluster randomised trial
- Author
-
Choko, Augustine T, Fielding, Katherine, Stallard, Nigel, Maheswaran, Hendramoorthy, Lepine, Aurelia, Desmond, Nicola, Kumwenda, Moses K, and Corbett, Elizabeth L
- Subjects
Male ,Token Economy ,Malawi ,Adaptive trials ,Reminder Systems ,HIV self-testing ,Cluster randomised trials ,wa_395 ,wc_503 ,HIV Infections ,wa_310 ,Study Protocol ,Clinical Protocols ,Predictive Value of Tests ,Pregnancy ,Humans ,Mass Screening ,Spouses ,Motivation ,lcsh:R5-920 ,Multi-arm multi-stage ,HIV ,Prenatal Care ,Patient Acceptance of Health Care ,w_20.5 ,Telephone ,Self Care ,Sexual Partners ,Research Design ,qw_160 ,Female ,Reagent Kits, Diagnostic ,lcsh:Medicine (General) - Abstract
Background Despite large-scale efforts to diagnose people living with HIV, 54% remain undiagnosed in sub-Saharan Africa. The gap in knowledge of HIV status and uptake of follow-on services remains wide with much lower rates of HIV testing among men compared to women. Here, we design a study to investigate the effect on uptake of HIV testing and linkage into care or prevention of partner-delivered HIV self-testing alone or with an additional intervention among male partners of pregnant women. Methods A phase II, adaptive, multi-arm, multi-stage cluster randomised trial, randomising antenatal clinic (ANC) days to six different trial arms. Pregnant women accessing ANC in urban Malawi for the first time will be recruited into either the standard of care (SOC) arm (invitation letter to the male partner offering HIV testing) or one of five intervention arms offering oral HIV self-test kits. Three of the five intervention arms will additionally offer the male partner a financial incentive (fixed or lottery amount) conditional on linkage after self-testing with one arm testing phone call reminders. Assuming that 25% of male partners link to care or prevention in the SOC arm, six clinic days, with a harmonic mean of 21 eligible participants, per arm will provide 80% power to detect a 0.15 absolute difference in the primary outcome. Cluster proportions will be analysed by a cluster summaries approach with adjustment for clustering and multiplicity. Discussion This trial applies adaptive methods which are novel and efficient designs. The methodology and lessons learned here will be important as proof of concept of how to design and conduct similar studies in the future. Although small, this trial will potentially present good evidence on the type of effective interventions for improving linkage into ART or prevention. The trial results will also have important policy implications on how to implement HIVST targeting male partners of pregnant women who are accessing ANC for the first time while paying particular attention to safety concerns. Contamination may occur if women in the intervention arms share their self-test kits with women in the SOC arm. Trial registration ISRCTN, ID: 18421340. Registered on 31 March 2016. Electronic supplementary material The online version of this article (doi:10.1186/s13063-017-2093-2) contains supplementary material, which is available to authorized users.
- Published
- 2017
20. Applying user preferences to optimize the contribution of HIV self-testing to reaching the 'first 90' target of UNAIDS Fast-track strategy: results from discrete choice experiments in Zimbabwe
- Author
-
Sibanda, Euphemia L, d'Elbée, Marc, Maringwa, Galven, Ruhode, Nancy, Tumushime, Mary, Madanhire, Claudius, Ong, Jason J, Indravudh, Pitchaya, Watadzaushe, Constancia, Johnson, Cheryl C, Hatzold, Karin, Taegtmeyer, Miriam, Hargreaves, James R, Corbett, Elizabeth L, Cowan, Frances M, and Terris-Prestholt, Fern
- Abstract
INTRODUCTION: New HIV testing strategies are needed to reach the United Nations' 90-90-90 target. HIV self-testing (HIVST) can increase uptake, but users' perspectives on optimal models of distribution and post-test services are uncertain. We used discrete choice experiments (DCEs) to explore the impact of service characteristics on uptake along the testing cascade. METHODS: DCEs are a quantitative survey method that present respondents with repeated choices between packages of service characteristics, and estimate relative strengths of preferences for service characteristics. From June to October 2016, we embedded DCEs within a population-based survey following door-to-door HIVST distribution by community volunteers in two rural Zimbabwean districts: one DCE addressed HIVST distribution preferences; and the other preferences for linkage to confirmatory testing (LCT) following self-testing. Using preference coefficients/utilities, we identified key drivers of uptake for each service and simulated the effect of changes of outreach and static/public clinics' characteristics on LCT. RESULTS: Distribution and LCT DCEs surveyed 296/329 (90.0%) and 496/594 (83.5%) participants; 81.8% and 84.9% had ever-tested, respectively. The strongest distribution preferences were for: (1) free kits - a $1 increase in the kit price was associated with a disutility (U) of -2.017; (2) door-to-door kit delivery (U = +1.029) relative to collection from public/outreach clinic; (3) telephone helpline for pretest support relative to in-person or no support (U = +0.415); (4) distributors from own/local village (U = +0.145) versus those from external communities. Participants who had never HIV tested valued phone helplines more than those previously tested. The strongest LCT preferences were: (1) immediate antiretroviral therapy (ART) availability: U = +0.614 and U = +1.052 for public and outreach clinics, respectively; (2) free services: a $1 user fee increase decreased utility at public (U = -0.381) and outreach clinics (U = -0.761); (3) proximity of clinic (U = -0.38 per hour walking). Participants reported willingness to link to either location; but never-testers were more averse to LCT. Simulations showed the importance of availability of ART: ART unavailability at public clinics would reduce LCT by 24%. CONCLUSIONS: Free HIVST distribution by local volunteers and immediately available ART were the strongest relative preferences identified. Accommodating LCT preferences, notably ensuring efficient provision of ART, could facilitate "resistant testers" to test while maximizing uptake of post-test services.
- Published
- 2019
21. The Self-Testing AfRica (STAR) Initiative: accelerating global access and scale-up of HIV self-testing
- Author
-
Ingold, Heather, Mwerinde, Ombeni, Ross, Anna Laura, Leach, Ross, Corbett, Elizabeth L, Hatzold, Karin, Johnson, Cheryl C, Ncube, Getrude, Nyirenda, Rose, and Baggaley, Rachel C
- Abstract
INTRODUCTION: HIV self-testing (HIVST) was first proposed as an additional option to standard HIV testing services in the 1980s. By 2015, two years after the first HIVST kit was approved for the American market and the year in which Unitaid invested in the "HIV Self-Testing AfRica (STAR) Initiative," HIVST remained unexplored with negligible access in low- and middle-income countries (LMIC). However, rapid progress had been made. This commentary outlines the interlinked market, regulatory and policy barriers that had inhibited product development and kept HIVST out of LMIC policy. We detail the components of STAR that enabled rapid HIVST scale-up, including critical investments in implementation, research, market forecasting, and engagement with manufacturers and regulators. DISCUSSION: The STAR Initiative has generated crucial information about how to distribute HIVST products effectively, ethically and efficiently. Service delivery models range from clinic-based distribution to workplace and partner-delivered approaches to reach first-time male testers, to community outreach to sex workers and general population "hotspots." These data directly informed supportive policy, notably the 2016 WHO guidelines strongly recommending HIVST as an additional testing approach, and regulatory change through support for WHO prequalification of the first HIVST kit in 2017. In July 2015, only two countries had national HIVST policies and were implementing HIVST. Three years later, 59 countries have policies, actively implemented in 28, with an additional 53 countries reporting policies under development. By end-November 2018 several quality-assured HIVST products had been registered, including two WHO prequalified tests. STAR Initiative countries have drafted regulations governing in vitro diagnostics, including HIVST products. With enabling policies, pre-qualification and regulations in place, donor procurement of kits has increased rapidly, to a forecasted estimate of 16 million HIVST kits procured by 2020. CONCLUSIONS: The STAR Initiative provided a strong foundation to introduce HIVST in LMICs and allow for rapid scale-up based on the wealth of multi-country evidence gathered. Together with sustained coordination and acceleration of market development work, HIVST can help address the testing gap and provide a focused and cost-effective means to expand access to treatment and prevention services.
- Published
- 2019
22. Ability to understand and correctly follow HIV self-test kit instructions for use: applying the cognitive interview technique in Malawi and Zambia
- Author
-
Simwinga, Musonda, Kumwenda, Moses K, Dacombe, Russell J, Kayira, Lusungu, Muzumara, Agness, Johnson, Cheryl C, Indravudh, Pitchaya, Sibanda, Euphemia L, Nyirenda, Lot, Hatzold, Karin, Corbett, Elizabeth L, Ayles, Helen, and Taegtmeyer, Miriam
- Abstract
INTRODUCTION: The ability to achieve an accurate test result and interpret it correctly is critical to the impact and effectiveness of HIV self-testing (HIVST). Simple and easy-to-use devices, instructions for use (IFU) and other support tools have been shown to be key to good performance in sub-Saharan Africa and may be highly contextual. The objective of this study was to explore the utility of cognitive interviewing in optimizing the local understanding of manufacturers' IFUs to achieve an accurate HIVST result. METHODS: Functionally literate and antiretroviral therapy-naive participants were purposefully selected between May 2016 and June 2017 to represent intended users of HIV self-tests from urban and rural areas in Malawi and Zambia. Participants were asked to follow IFUs for HIVST. We then conducted cognitive interviews and observed participants while they attempted to complete the HIVST steps using a structured guide, which mirrored the steps in the IFU. Qualitative data were analysed using a thematic approach. RESULTS: Of a total of 61 participants, many successfully performed most steps in the IFU. Some had difficulties in understanding these and made errors, which could have led to incorrect test results, such as incorrect use of buffer and reading the results prematurely. Participants with lower levels of literacy and inexperience with standard pictorial images were more likely to struggle with IFUs. Difficulties tended to be more pronounced among those in rural settings. Ambiguous terms and translations in the IFU, unfamiliar images and symbols, and unclear order of the steps to be followed were most commonly linked to errors and lower comprehension among participants. Feedback was provided to the manufacturer on the findings, which resulted in further optimization of IFUs. CONCLUSIONS: Cognitive interviewing identifies local difficulties in conducting HIVST from manufacturer-translated IFUs. It is a useful and practical methodology to optimize IFUs and make them more understandable.
- Published
- 2019
23. HIV self-testing: breaking the barriers to uptake of testing among men and adolescents in sub-Saharan Africa, experiences from STAR demonstration projects in Malawi, Zambia and Zimbabwe
- Author
-
Hatzold, Karin, Gudukeya, Stephano, Mutseta, Miriam N, Chilongosi, Richard, Nalubamba, Mutinta, Nkhoma, Chiwawa, Munkombwe, Hambweka, Munjoma, Malvern, Mkandawire, Phillip, Mabhunu, Varaidzo, Smith, Gina, Madidi, Ngonidzashe, Ahmed, Hussein, Kambeu, Taurai, Stankard, Petra, Johnson, Cheryl C, and Corbett, Elizabeth L
- Abstract
INTRODUCTION: Social, structural and systems barriers inhibit uptake of HIV testing. HIV self-testing (HIVST) has shown promising uptake by otherwise underserved priority groups including men, young people and first-time testers. Here, we use characteristics of HIVST kit recipients to investigate delivery to these priority groups during HIVST scale-up in three African countries. METHODS: Kit distributors collected individual-level age, sex and testing history from all clients. These data were aggregated and analysed by country (Malawi, Zambia and Zimbabwe) for five distribution models: local community-based distributor (CBD: door-to-door, street and local venues), workplace distribution (WD), integration into HIV testing services (IHTS), or public health facilities (IPHF) and during demand creation for voluntary male medical circumcision (VMMC). Used kits were collected and re-read from CBD and IHTS recipients. RESULTS: Between May 2015 and July 2017, 628,705 HIVST kits were distributed in Malawi (172,830), Zambia (190,787) and Zimbabwe (265,091). Community-based models, the first to be established, accounted for 519,658 (82.7%) of kits distributed, with 275,419 (53.0%) used kits returned. Subsequent model diversification delivered 54,453 (8.7%) test-kits through IHTS, 23,561 (3.7%) through VMMC, 21,183 (3.4%) through IPHF and 9850 (1.7%) through WD. Men took 294,508 (48.2%) kits, and 263,073 (43.1%) went to young people (16 to 24 years). A higher proportion of male self-testers (65,577; 22.3%) were first-time testers than women (54,096; 17.1%) with this apparent in Zimbabwe (16.2% vs. 11.4%), Zambia (25.4% vs. 17.7%) and Malawi (27.9% vs. 25.9%). The highest proportions of first-time testers were in young (16 to 24 years) and older (>50 years) men (country-ranges: 18.7% to 35.9% and 13.8% to 26.8% respectively). Most IHTS clients opted for HIVST in preference to standard HTS in each of 12 delivery sites, with those selecting HIVST having lower HIV prevalence, potentially due to self-selection. CONCLUSIONS: HIVST delivered at scale using several different models reached a high proportion of men, young people and first-time testers in Malawi, Zambia and Zimbabwe, some of whom may not have tested otherwise. As men and young people have limited uptake under standard facility-and community-based HIV testing, innovative male- and youth-sensitive approaches like HIVST may be essential to reaching UNAIDS fast-track targets for 2020.
- Published
- 2019
24. Exploring social harms during distribution of HIV self-testing kits using mixed-methods approaches in Malawi
- Author
-
Kumwenda, Moses K, Johnson, Cheryl C, Choko, Augustine T, Lora, Wezzie, Sibande, Wakumanya, Sakala, Doreen, Indravudh, Pitchaya, Chilongosi, Richard, Baggaley, Rachael C, Nyirenda, Rose, Taegtmeyer, Miriam, Hatzold, Karin, Desmond, Nicola, and Corbett, Elizabeth L
- Abstract
INTRODUCTION: HIV self-testing (HIVST) provides couples and individuals with a discreet, convenient and empowering testing option. As with all HIV testing, potential harms must be anticipated and mitigated to optimize individual and public health benefits. Here, we describe social harms (SHs) reported during HIVST implementation in Malawi, and propose a framework for grading and responding to harms, according to their severity. METHODS: We report findings from six HIVST implementation studies in Malawi (2011 to 2017) that included substudies investigating SH reports. Qualitative methods included focus group discussions, in-depth interviews and critical incident interviews. Earlier studies used intensive quantitative methods (post-test questionnaires for intimate partner violence, household surveys, investigation of all deaths in HIVST communities). Later studies used post-marketing reporting with/without community engagement. Pharmacovigilance methodology (whereby potentially life-threatening/changing events are defined as "serious") was used to grade SH severity, assuming more complete passive reporting for serious events. RESULTS: During distribution of 175,683 HIVST kits, predominantly under passive SH reporting, 25 serious SHs were reported from 19 (0.011%) self-testers, including 15 partners in eight couples with newly identified HIV discordancy, and one perinatally infected adolescent. There were no deaths or suicides. Marriage break-up was the most commonly reported serious SH (sixteen individuals; eight couples), particularly among serodiscordant couples. Among new concordant HIV-positive couples, blame and frustration was common but rarely (one episode) led to serious SHs. Among concordant HIV-negative couples, increased trust and stronger relationships were reported. Coercion to test or disclose was generally considered "well-intentioned" within established couples. Women felt empowered and were assertive when offering HIVST test kits to their partners. Some women who persuaded their partner to test, however, did report SHs, including verbal or physical abuse and economic hardship. CONCLUSIONS: After more than six years of large-scale HIVST implementation and in-depth investigation of SHs in Malawi, we identified approximately one serious reported SH per 10,000 HIVST kits distributed, predominantly break-up of married serodiscordant couples. Both "active" and "passive" reporting systems identified serious SH events, although with more complete capture by "active" systems. As HIVST is scaled-up, efforts to support and further optimize community-led SH monitoring should be prioritized alongside HIVST distribution.
- Published
- 2019
25. Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study
- Author
-
Reddy, Krishna P, Gupta-Wright, Ankur, Fielding, Katherine L, Costantini, Sydney, Zheng, Amy, Corbett, Elizabeth L, Yu, Liyang, van Oosterhout, Joep J, Resch, Stephen C, Wilson, Douglas P, Horsburgh, C Robert, Wood, Robin, Alufandika-Moyo, Melanie, Peters, Jurgens A, Freedberg, Kenneth A, Lawn, Stephen D, and Walensky, Rochelle P
- Subjects
health care economics and organizations - Abstract
BACKGROUND: Testing urine improves the number of tuberculosis diagnoses made among patients in hospital with HIV. In conjunction with the two-country randomised Rapid Urine-based Screening for Tuberculosis to Reduce AIDS-related Mortality in Hospitalised Patients in Africa (STAMP) trial, we used a microsimulation model to estimate the effects on clinical outcomes and the cost-effectiveness of adding urine-based tuberculosis screening to sputum screening for hospitalised patients with HIV. METHODS: We compared two tuberculosis screening strategies used irrespective of symptoms among hospitalised patients with HIV in Malawi and South Africa: a GeneXpert assay (Cepheid, Sunnyvale, CA, USA) for Mycobacterium tuberculosis and rifampicin resistance (Xpert) in sputum samples (standard of care) versus sputum Xpert combined with a lateral flow assay for M tuberculosis lipoarabinomannan in urine (Determine TB-LAM Ag test, Abbott, Waltham, MA, USA [formerly Alere]; TB-LAM) and concentrated urine Xpert (intervention). A cohort of simulated patients was modelled using selected characteristics of participants, tuberculosis diagnostic yields, and use of hospital resources in the STAMP trial. We calibrated 2-month model outputs to the STAMP trial results and projected clinical and economic outcomes at 2 years, 5 years, and over a lifetime. We judged the intervention to be cost-effective if the incremental cost-effectiveness ratio (ICER) was less than US$750/year of life saved (YLS) in Malawi and $940/YLS in South Africa. A modified intervention of adding only TB-LAM to the standard of care was also evaluated. We did a budget impact analysis of countrywide implementation of the intervention. FINDINGS: The intervention increased life expectancy by 0·5-1·2 years and was cost-effective, with an ICER of $450/YLS in Malawi and $840/YLS in South Africa. The ICERs decreased over time. At lifetime horizon, the intervention remained cost-effective under nearly all modelled assumptions. The modified intervention was at least as cost-effective as the intervention (ICERs $420/YLS in Malawi and $810/YLS in South Africa). Over 5 years, the intervention would save around 51 000 years of life in Malawi and around 171 000 years of life in South Africa. Health-care expenditure for screened individuals was estimated to increase by $37 million (10·8%) and $261 million (2·8%), respectively. INTERPRETATION: Urine-based tuberculosis screening of all hospitalised patients with HIV could increase life expectancy and be cost-effective in resource-limited settings. Urine TB-LAM is especially attractive because of high incremental diagnostic yield and low additional cost compared with sputum Xpert, making a compelling case for expanding its use to all hospitalised patients with HIV in areas with high HIV burden and endemic tuberculosis. FUNDING: UK Medical Research Council, UK Department for International Development, Wellcome Trust, US National Institutes of Health, Royal College of Physicians, Massachusetts General Hospital.
- Published
- 2019
26. Risk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: Derivation and external validation cohort study
- Author
-
Gupta-Wright, Ankur, Corbett, Elizabeth L, WILSON, Douglas, van Oosterhout, Joep, Dheda, Keertan, HUERGA, Helena, Peter, Jonny, Bonnet, Maryline, Alufandika-Moyo, Melanie, Grint, Daniel, D.Lawn, Stephen, Fielding, Katherine, Malawi Liverpool Wellcome Trust Clinical Research Programme (MLW), University of Liverpool-Liverpool School of Tropical Medicine (LSTM)-University of Malawi-Wellcome Trust, University of Malawi, University of KwaZulu-Natal (UKZN), University of Cape Town, Recherches Translationnelles sur le VIH et les maladies infectieuses endémiques er émergentes (TransVIHMI), Université Cheikh Anta Diop [Dakar, Sénégal] (UCAD)-Institut de Recherche pour le Développement (IRD)-Université de Yaoundé I-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Université Montpellier 1 (UM1), Department of Infectious Disease Epidemiology [London] (DIDE), Imperial College London, University of the Witwatersrand [Johannesburg] (WITS), Liverpool School of Tropical Medicine (LSTM)-University of Liverpool-Wellcome Trust-University of Malawi, University of KwaZulu-Natal [Durban, Afrique du Sud] (UKZN), Recherches Translationnelles sur le VIH et les maladies infectieuses endémiques et émergentes (TransVIHMI), and Institut de Recherche pour le Développement (IRD)-Université de Yaoundé I-Université Cheikh Anta Diop [Dakar, Sénégal] (UCAD)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)
- Subjects
Lipopolysaccharides ,Male ,Bacterial Diseases ,Physiology ,HIV Infections ,MESH: Hospitalization ,MESH: Africa ,Urine ,Cohort Studies ,Mathematical and Statistical Techniques ,MESH: Risk Factors ,Risk Factors ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,MESH: South of the Sahara ,Medicine and Health Sciences ,Mass Screening ,MESH: Tuberculosis ,Public and Occupational Health ,MESH: Inpatients ,MESH: Cohort Studies ,MESH: AIDS-Related Opportunistic Infections ,MESH: HIV ,MESH: Research Design ,Statistics ,MESH: Urinalysis ,MESH: HIV Infections ,Prognosis ,Vaccination and Immunization ,Hospitals ,Body Fluids ,Hospitalization ,Infectious Diseases ,Research Design ,MESH: Survival Analysis ,Physical Sciences ,Medicine ,Tuberculosis Diagnosis and Management ,Female ,Anatomy ,Research Article ,Adult ,Death Rates ,Immunology ,Antiretroviral Therapy ,Urinalysis ,Research and Analysis Methods ,MESH: Prognosis ,Population Metrics ,Antiviral Therapy ,Diagnostic Medicine ,Humans ,Tuberculosis ,MESH: Mass Screening ,Statistical Methods ,Africa South of the Sahara ,Inpatients ,MESH: Humans ,AIDS-Related Opportunistic Infections ,Population Biology ,HIV ,Biology and Life Sciences ,MESH: Adult ,Tropical Diseases ,Survival Analysis ,MESH: Male ,Health Care ,Health Care Facilities ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,Preventive Medicine ,MESH: Lipopolysaccharides ,MESH: Female ,Mathematics ,Forecasting - Abstract
Background The prevalence of and mortality from HIV-associated tuberculosis (HIV/TB) in hospital inpatients in Africa remains unacceptably high. Currently, there is a lack of tools to identify those at high risk of early mortality who may benefit from adjunctive interventions. We therefore aimed to develop and validate a simple clinical risk score to predict mortality in high-burden, low-resource settings. Methods and findings A cohort of HIV-positive adults with laboratory-confirmed TB from the STAMP TB screening trial (Malawi and South Africa) was used to derive a clinical risk score using multivariable predictive modelling, considering factors at hospital admission (including urine lipoarabinomannan [LAM] detection) thought to be associated with 2-month mortality. Performance was evaluated internally and then externally validated using independent cohorts from 2 other studies (LAM-RCT and a Médecins Sans Frontières [MSF] cohort) from South Africa, Zambia, Zimbabwe, Tanzania, and Kenya. The derivation cohort included 315 patients enrolled from October 2015 and September 2017. Their median age was 36 years (IQR 30–43), 45.4% were female, median CD4 cell count at admission was 76 cells/μl (IQR 23–206), and 80.2% (210/262) of those who knew they were HIV-positive at hospital admission were taking antiretroviral therapy (ART). Two-month mortality was 30% (94/315), and mortality was associated with the following factors included in the score: age 55 years or older, male sex, being ART experienced, having severe anaemia (haemoglobin < 80 g/l), being unable to walk unaided, and having a positive urinary Determine TB LAM Ag test (Alere). The score identified patients with a 46.4% (95% CI 37.8%–55.2%) mortality risk in the high-risk group compared to 12.5% (95% CI 5.7%–25.4%) in the low-risk group (p < 0.001). The odds ratio (OR) for mortality was 6.1 (95% CI 2.4–15.2) in high-risk patients compared to low-risk patients (p < 0.001). Discrimination (c-statistic 0.70, 95% CI 0.63–0.76) and calibration (Hosmer-Lemeshow statistic, p = 0.78) were good in the derivation cohort, and similar in the external validation cohort (complete cases n = 372, c-statistic 0.68 [95% CI 0.61–0.74]). The validation cohort included 644 patients between January 2013 and August 2015. Median age was 36 years, 48.9% were female, and median CD4 count at admission was 61 (IQR 21–145). OR for mortality was 5.3 (95% CI 2.2–9.5) for high compared to low-risk patients (complete cases n = 372, p < 0.001). The score also predicted patients at higher risk of death both pre- and post-discharge. A simplified score (any 3 or more of the predictors) performed equally well. The main limitations of the scores were their imperfect accuracy, the need for access to urine LAM testing, modest study size, and not measuring all potential predictors of mortality (e.g., tuberculosis drug resistance). Conclusions This risk score is capable of identifying patients who could benefit from enhanced clinical care, follow-up, and/or adjunctive interventions, although further prospective validation studies are necessary. Given the scale of HIV/TB morbidity and mortality in African hospitals, better prognostic tools along with interventions could contribute towards global targets to reduce tuberculosis mortality., Author summary Why was this study done? HIV-associated tuberculosis (TB) is very common in hospitals in sub-Saharan Africa, and is a major cause of morbidity and mortality. There is a lack of tools to identify which patients are more likely to die early; therefore, these patients cannot be targeted for more intensive clinical care or other treatments in addition to TB antibiotics and antiretroviral drugs. A new urine TB diagnostic test (detecting a substance called lipoarabinomannan [LAM]) can identify patients at higher risk of dying and, along with other simply measured clinical signs or symptoms, may be useful for predicting which patients are most likely to do poorly. What did the researchers do and find? We used data from HIV-positive adults admitted to hospital in Malawi and South Africa and diagnosed with TB to develop a simple clinical risk score to identify patients with a 50% chance of dying within 2 months. The score included 6 factors that can be measured at admission to hospital, including the results of the urine TB test, presence of anaemia, and some demographic factors. We then tested the performance of the risk score using data from studies of different patients from sub-Saharan Africa, and it performed similarly. The score was able to identify patients at higher risk of dying during admission to hospital, and after discharge from hospital. What do these findings mean? This score could be used to identify patients admitted to hospital and diagnosed with HIV-associated TB who may benefit most from more intensive clinical care, additional treatments, and/or closer follow-up after discharge. It could also be used as a research tool to study new drugs or strategies aimed at reducing mortality from with HIV-associated TB. This is the first such tool to our knowledge in this patient population, and future studies could optimise such predictive tools, in particular if appropriate new interventions and/or diagnostics become available.
- Published
- 2019
27. Effect of the duration of antimicrobial exposure on the development of antimicrobial resistance (AMR) for macrolide antibiotics: protocol for a systematic review with a network meta-analysis
- Author
-
Divala, Titus H, Corbett, Elizabeth L, Stagg, Helen R, Nliwasa, Marriott, Sloan, Derek J, French, Neil, Fielding, Katherine L, University of St Andrews. School of Medicine, and University of St Andrews. Infection and Global Health Division
- Subjects
Carriage ,T-NDAS ,lcsh:R ,lcsh:Medicine ,Resistance mechanisms ,Antimicrobial resistance ,Disease recurrence ,Treatment duration ,Prescriptions ,Streptococcus pneumoniae ,Treatment failure ,SDG 3 - Good Health and Well-being ,RA0421 ,RA0421 Public health. Hygiene. Preventive Medicine ,Macrolides ,Network meta-analysis - Abstract
THD is funded by the Commonwealth Scholarship Commission and the Helse Nord RHF. This review is part of his PhD work at LSHTM. ELC is funded by a Wellcome Trust Senior Research Fellowship in Clinical Science: WT200901. HRS is supported by the Medical Research Council [MR/R008345/1]. Background: Antimicrobial resistance generates a huge health and economic burden and has the potential to become the leading cause of death globally, but its underlying drivers are yet to be fully described. The association between a microbe’s exposure to antimicrobials and subsequent development of, or selection for, resistance is well documented, as are the exacerbating microbial and human factors. However, the nature and extent of this risk, and how it varies by antimicrobial class and duration of treatment, is poorly defined. The goal of our systematic review and network meta-analysis is to determine the relationship between the duration of antimicrobial exposure and selection for resistance. We will use macrolides as the antimicrobial class of interest and Streptococcus pneumoniae carriage as an indicator organism. Our secondary outcomes include duration of symptoms, risk of treatment failure and recurrence, and descriptions of resistance mechanisms. Methods: We will conduct a systematic review, selecting studies if they are published randomised controlled trials (RCTs) which report the relationship between taking a macrolide for any indication and incidence of resistant Streptococcus pneumoniae in patients of any age group. We will use a predefined search strategy to identify studies meeting these eligibility criteria in MEDLINE, Embase, Global Health and the Cochrane Central Register of RCTs. Two authors will independently screen titles and abstracts, review the full texts and undertake data extraction. We will use the Cochrane Collaboration’s tool to assess the quality of included RCTs. If feasible, we will perform pair-wise meta-analysis modelling to determine the relationship between the duration of macrolide treatment and development of macrolide resistant Streptococcus pneumoniae. If the identified studies meet the assumptions for a network meta-analysis (NMA), we will additionally model this relationship using indirect comparisons. Our protocol utilises reporting guidance by Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) and the extensions for protocols (PRISMA-P) and network meta-analyses (PRISMA for NMA). Our review will also report to these standards. Discussion: Establishing the relationship between the duration of antimicrobial exposure and development of, or selection for, resistance will inform the design of antimicrobial prescriptions, treatment guidelines and the behaviour of both physicians and patients. This work will therefore be a strong contribution towards the full realisation of current antimicrobial resistance stewardship strategies. Publisher PDF
- Published
- 2018
28. Sensitivity and specificity of using trial-of-antibiotics versus sputum mycobacteriology for diagnosis of tuberculosis: protocol for a systematic literature review
- Author
-
Divala, Titus H., Fielding, Katherine L., Nliwasa, Marriott, Sloan, Derek J., Gupta-Wright, Ankur, and Corbett, Elizabeth L.
- Subjects
Adult ,lcsh:R ,Sputum ,Protocol ,Humans ,lcsh:Medicine ,Mycobacterium tuberculosis ,Sensitivity and Specificity ,Tuberculosis, Pulmonary ,Anti-Bacterial Agents - Abstract
Background Suboptimal diagnostics for pulmonary tuberculosis (PTB) drives use of ‘trial-of-antibiotics (non-tuberculosis)’ in an attempt to distinguish PTB patients from those with bacterial lower respiratory tract infection (LRTI). The underlying assumption—that patients with LRTI will report ‘response’ to broad-spectrum antibiotics, while those with PTB will not—has minimal evidence base for such a widely used intervention. Numerous potential causes of misclassification include bacterial super-infection of active PTB, placebo effect, and antimicrobial resistance (AMR). The main aim of this systematic review is to collate available evidence on the performance of trial-of-antibiotics as a diagnostic test and to explore the timing, interpretation, and decision-making process. Methods We will search MEDLINE, Embase, and Global Health using the Ovid platform for published studies that recruited adults being investigated for PTB, performed trial-of-antibiotics accompanied by mycobacteriological investigations, and reported both diagnostic test outcomes at the individual level. Following article selection, two authors will independently review titles and abstracts against eligibility criteria then perform full-text screening and extraction into a spreadsheet. We will conduct a risk of bias assessment at the level of the study using QUADAS-2 (University of Bristol) tool that assesses diagnostic evaluation work in four domains: (1) patient selection, (2) the index test, (3) the reference standard, and (4) patient flow and timing of tests. We will perform a narrative synthesis and, where possible, meta-analyses addressing our primary outcome. Our protocol adheres to the standards recommended by the PRISMA-P. Discussion Pooling all available evidence on the accuracy, approach, and interpretation of results of trial-of-antibiotics in the context of PTB diagnosis will meet an urgent need, considering the widespread utilisation and potential for antimicrobial resistance. We therefore believe that our findings will have impact on policy and that they will inform the design of future detailed investigations into this important diagnostic approach. Systematic review registration PROSPERO CRD42017083915 Electronic supplementary material The online version of this article (10.1186/s13643-018-0806-6) contains supplementary material, which is available to authorized users.
- Published
- 2018
29. Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial
- Author
-
Gupta-Wright, Ankur, Corbett, Elizabeth L, van Oosterhout, Joep J, Wilson, Douglas, Grint, Daniel, Alufandika-Moyo, Melanie, Peters, Jurgens A, Chiume, Lingstone, Flach, Clare, Lawn, Stephen D, and Fielding, Katherine
- Subjects
Adult ,Male ,Malawi ,wc_503_1 ,HIV Infections ,wa_395 ,Urinalysis ,Article ,South Africa ,Double-Blind Method ,Drug Resistance, Bacterial ,HIV Seropositivity ,Humans ,Mass Screening ,Tuberculosis ,Tuberculosis, Pulmonary ,Developing Countries ,Inpatients ,wa_30 ,AIDS-Related Opportunistic Infections ,Sputum ,Mycobacterium tuberculosis ,Middle Aged ,Female ,wf_200 ,wc_503_41 ,Rifampin - Abstract
BACKGROUND\ud Current diagnostics for HIV-associated tuberculosis are suboptimal, with missed diagnoses contributing to high hospital mortality and approximately 374 000 annual HIV-positive deaths globally. Urine-based assays have a good diagnostic yield; therefore, we aimed to assess whether urine-based screening in HIV-positive inpatients for tuberculosis improved outcomes.\ud \ud METHODS\ud We did a pragmatic, multicentre, double-blind, randomised controlled trial in two hospitals in Malawi and South Africa. We included HIV-positive medical inpatients aged 18 years or more who were not taking tuberculosis treatment. We randomly assigned patients (1:1), using a computer-generated list of random block size stratified by site, to either the standard-of-care or the intervention screening group, irrespective of symptoms or clinical presentation. Attending clinicians made decisions about care; and patients, clinicians, and the study team were masked to the group allocation. In both groups, sputum was tested using the Xpert MTB/RIF assay (Xpert; Cepheid, Sunnyvale, CA, USA). In the standard-of-care group, urine samples were not tested for tuberculosis. In the intervention group, urine was tested with the Alere Determine TB-LAM Ag (TB-LAM; Alere, Waltham, MA, USA), and Xpert assays. The primary outcome was all-cause 56-day mortality. Subgroup analyses for the primary outcome were prespecified based on baseline CD4 count, haemoglobin, clinical suspicion for tuberculosis; and by study site and calendar time. We used an intention-to-treat principle for our analyses. This trial is registered with the ISRCTN registry, number ISRCTN71603869.\ud \ud FINDINGS\ud Between Oct 26, 2015, and Sept 19, 2017, we screened 4788 HIV-positive adults, of which 2600 (54%) were randomly assigned to the study groups (n=1300 for each group). 13 patients were excluded after randomisation from analysis in each group, leaving 2574 in the final intention-to-treat analysis (n=1287 in each group). At admission, 1861 patients were taking antiretroviral therapy and median CD4 count was 227 cells per μL (IQR 79-436). Mortality at 56 days was reported for 272 (21%) of 1287 patients in the standard-of-care group and 235 (18%) of 1287 in the intervention group (adjusted risk reduction [aRD] -2·8%, 95% CI -5·8 to 0·3; p=0·074). In three of the 12 prespecified, but underpowered subgroups, mortality was lower in the intervention group than in the standard-of-care group for CD4 counts less than 100 cells per μL (aRD -7·1%, 95% CI -13·7 to -0·4; p=0.036), severe anaemia (-9·0%, -16·6 to -1·3; p=0·021), and patients with clinically suspected tuberculosis (-5·7%, -10·9 to -0·5; p=0·033); with no difference by site or calendar period. Adverse events were similar in both groups.\ud \ud INTERPRETATION\ud Urine-based tuberculosis screening did not reduce overall mortality in all HIV-positive inpatients, but might benefit some high-risk subgroups. Implementation could contribute towards global targets to reduce tuberculosis mortality.\ud \ud FUNDING\ud Joint Global Health Trials Scheme of the Medical Research Council, the UK Department for International Development, and the Wellcome Trust.
- Published
- 2018
30. Measuring sexual behaviour in Malawi: a triangulation of three data collection instruments
- Author
-
Desmond, Nicola, Nagelkerke, Nico, Lora, Wezzie, Chipeta, Effie, Sambo, Mwiza, Kumwenda, Moses, Corbett, Elizabeth L., Taegtemeyer, Miriam, Seeley, Janet, Lalloo, David G., and Theobald, Sally
- Subjects
Coital diaries ,Adult ,Male ,Malawi ,wm_100 ,Adolescent ,wc_503_1 ,Sexual Behavior ,HIV self-testing ,HIV Infections ,wa_395 ,Sexual behaviour ,Young Adult ,Humans ,Mass Screening ,Prospective Studies ,Retrospective Studies ,Measurement ,lcsh:Public aspects of medicine ,Data Collection ,Reproducibility of Results ,lcsh:RA1-1270 ,Middle Aged ,ACASI ,Diaries as Topic ,Self Care ,Sexual Partners ,Mental Recall ,Female ,Self Report ,Research Article - Abstract
Background There is a need for valid approaches to measure sexual interactions to assess the impact of behavioural interventions and to predict the impact of behaviour changes. Different methods of asking about sexual behaviour often yield conflicting answers and men often report higher levels of heterosexual activity than women. To better understand self-reported sexual behaviour data and how best to collect it, we analyzed data collected as part of a larger project (ST IMPACTS) on the social and behavioural impact of introducing community-level HIV self-testing (HIVST) with counseling (semi-supervised with pre- and generic post-test counseling provided on delivery or collection of test kits) in an urban Malawian setting. Methods Information on sexual behaviour was collected from HIV self-testers over a three-month period. Three different methods were used: retrospective face-to-face interviews (FTFI); audio computer assisted self-interviews (ACASI) and a prospective coital diary. Both retrospective instruments were used before and after the three-month study period. Frequency and cross-tabulation, as well as scatterplots, were used for exploratory analyses. Chi-square tests were used to test for differences in proportions. Spearman’s correlation coefficient was used to explore associations between both continuous and ordinal variables and Wilcoxon’s paired sample and Mann-Whitney test was used to test for differences in such variables or between variables. Results There was reasonable agreement between the two retrospective methods although both yielded inconsistent answers e.g. with lower reported numbers of life-time sexual partners at the end than at the beginning of the study period. The diary method elicited higher reported levels of sex with multiple partners than both retrospective instruments which may be due to inadequate recall. Over the study period 37.4% of men and 19.7% of women reported multiple sexual partners using the diary. There was no clear relationship between reported sexual behaviour and HIV status (prevalence 9.6%). Conclusions Diaries may therefore have higher validity for sensitive behaviour reporting and thus be the preferred method in similar African contexts in measuring sexual behaviours. Electronic supplementary material The online version of this article (10.1186/s12889-018-5717-x) contains supplementary material, which is available to authorized users.
- Published
- 2018
31. A Bayesian Approach to Understanding Sex Differences in Tuberculosis Disease Burden
- Author
-
Horton, Katherine C, Sumner, Tom, Houben, Rein M G J, Corbett, Elizabeth L, and White, Richard G
- Subjects
Adult ,Male ,Malawi ,Bayes theorem ,Adolescent ,Practice of Epidemiology ,time to treatment ,Incidence ,Antitubercular Agents ,Middle Aged ,Global Health ,Time-to-Treatment ,Young Adult ,tuberculosis ,Vietnam ,access to health care ,gender ,Prevalence ,sex ,Humans ,Female ,Sex Distribution ,Tuberculosis, Pulmonary ,mathematical model ,Aged - Abstract
Globally, men have a higher epidemiologic burden of tuberculosis (incidence, prevalence, mortality) than women do, possibly due to differences in disease incidence, treatment initiation, self-cure, and/or untreated-tuberculosis mortality rates. Using a simple, sex-stratified compartmental model, we employed a Bayesian approach to explore which factors most likely explain men’s higher burden. We applied the model to smear-positive pulmonary tuberculosis in Vietnam (2006–2007) and Malawi (2013–2014). Posterior estimates were consistent with sex-specific prevalence and notifications in both countries. Results supported higher incidence in men and showed that both sexes faced longer durations of untreated disease than estimated by self-reports. Prior untreated disease durations were revised upward 8- to 24-fold, to 2.2 (95% credible interval: 1.7, 2.9) years for men in Vietnam and 2.8 (1.8, 4.1) years for men in Malawi, approximately a year longer than for women in each country. Results imply that substantial sex differences in tuberculosis burden are almost solely attributable to men’s disadvantages in disease incidence and untreated disease duration. The latter, for which self-reports provide a poor proxy, implies inadequate coverage of case-finding strategies. These results highlight an urgent need for better understanding of gender-related barriers faced by men and support the systematic targeting of men for screening.
- Published
- 2018
32. Economic costs and health-related quality of life outcomes of hospitalised patients with high HIV prevalence: A prospective hospital cohort study in Malawi
- Author
-
Maheswaran, Hendramoorthy, Petrou, Stavros, Cohen, Danielle, MacPherson, Peter, Kumwenda, Felistas, Lalloo, David G., Corbett, Elizabeth L., and Clarke, Aileen
- Subjects
RNA viruses ,Bacterial Diseases ,Male ,Malawi ,Financial Management ,Economics ,lcsh:Medicine ,Social Sciences ,HIV Infections ,wc_503 ,Pathology and Laboratory Medicine ,Immunodeficiency Viruses ,Medicine and Health Sciences ,Prevalence ,Prospective Studies ,lcsh:Science ,HIV diagnosis and management ,Middle Aged ,Hospitals ,Hospitalization ,Infectious Diseases ,Anti-Retroviral Agents ,Medical Microbiology ,Viral Pathogens ,Viruses ,Costs and Cost Analysis ,Tuberculosis Diagnosis and Management ,Female ,Pathogens ,Research Article ,Adult ,Adolescent ,41b6e438 ,Microbiology ,d67ea616 ,Diagnostic Medicine ,Retroviruses ,Indirect Costs ,Tuberculosis ,Humans ,Microbial Pathogens ,lcsh:R ,Lentivirus ,Organisms ,Biology and Life Sciences ,HIV ,Tropical Diseases ,Miliary Tuberculosis ,Health Care ,Health Care Facilities ,Quality of Life ,lcsh:Q ,Finance - Abstract
Introduction: Although HIV infection and its associated co-morbidities remain the commonest reason for hospitalisation in Africa, their impact on economic costs and health-related quality of life (HRQoL) are not well understood. This information is essential for decision-makers to make informed choices about how to best scale-up anti-retroviral treatment (ART) programmes. This study aimed to quantify the impact of HIV infection and ART on economic outcomes in a prospective cohort of hospitalised patients with high HIV prevalence.\ud \ud Methods: Sequential medical admissions to Queen Elizabeth Central Hospital, Malawi, between June-December 2014 were followed until discharge, with standardised classification of medical diagnosis and estimation of healthcare resources used. Primary costing studies estimated total health provider cost by medical diagnosis. Participants were interviewed to establish direct non-medical and indirect costs. Costs were adjusted to 2014 US$ and INT$. HRQoL was measured using the EuroQol EQ-5D. Multivariable analyses estimated predictors of economic outcomes.\ud \ud Results: Of 892 eligible participants, 80.4% (647/892) were recruited and medical notes found. In total, 447/647 (69.1%) participants were HIV-positive, 339/447 (75.8%) were on ART prior to admission, and 134/647 (20.7%) died in hospital. Mean duration of admission for HIV-positive participants not on ART and HIV-positive participants on ART was 15.0 days (95%CI: 12.0-18.0) and 12.2 days (95%CI: 10.8-13.7) respectively, compared to 10.8 days (95%CI: 8.8-12.8) for HIV-negative participants. Mean total provider cost per hospital admission was US$74.78 (bootstrap 95%CI: US$25.41-US$124.15) higher for HIV-positive than HIV-negative participants. Amongst HIV-positive participants, the mean total provider cost was US$106.87 (bootstrap 95%CI: US$25.09-US$106.87) lower for those on ART than for those not on ART. The mean total direct non-medical and indirect cost per hospital admission was US$87.84. EQ-5D utility scores were lower amongst HIV-positive participants, but not significantly different between those on and not on ART. \ud \ud Conclusions: HIV-related hospital care poses substantial financial burdens on health systems and patients; however, per-admission costs are substantially lower for those already initiated onto ART prior to admission. These potential cost savings could offset some of the additional resources needed to provide universal access to ART.
- Published
- 2018
33. Economic costs and health-related quality of life outcomes of hospitalised patients with high HIV prevalence : a prospective hospital cohort study in Blantyre, Malawi
- Author
-
Maheswaran, Hendramoorthy, Petrou, Stavros, Cohen, D., MacPherson, Peter, Kumwenda, F., Laloo, D. G., Corbett, Elizabeth L., and Clarke, Aileen
- Subjects
RA ,RC - Abstract
Introduction\ud \ud Although HIV infection and its associated co-morbidities remain the commonest reason for hospitalisation in Africa, their impact on economic costs and health-related quality of life (HRQoL) are not well understood. This information is essential for decision-makers to make informed choices about how to best scale-up anti-retroviral treatment (ART) programmes. This study aimed to quantify the impact of HIV infection and ART on economic outcomes in a prospective cohort of hospitalised patients with high HIV prevalence.\ud \ud Methods\ud \ud Sequential medical admissions to Queen Elizabeth Central Hospital, Malawi, between June-December 2014 were followed until discharge, with standardised classification of medical diagnosis and estimation of healthcare resources used. Primary costing studies estimated total health provider cost by medical diagnosis. Participants were interviewed to establish direct non-medical and indirect costs. Costs were adjusted to 2014 US$ and INT$. HRQoL was measured using the EuroQol EQ-5D. Multivariable analyses estimated predictors of economic outcomes.\ud \ud Results\ud \ud Of 892 eligible participants, 80.4% (647/892) were recruited and medical notes found. In total, 447/647 (69.1%) participants were HIV-positive, 339/447 (75.8%) were on ART prior to admission, and 134/647 (20.7%) died in hospital. Mean duration of admission for HIV-positive participants not on ART and HIV-positive participants on ART was 15.0 days (95%CI: 12.0–18.0) and 12.2 days (95%CI: 10.8–13.7) respectively, compared to 10.8 days (95%CI: 8.8–12.8) for HIV-negative participants. Mean total provider cost per hospital admission was US$74.78 (bootstrap 95%CI: US$25.41-US$124.15) higher for HIV-positive than HIV-negative participants. Amongst HIV-positive participants, the mean total provider cost was US$106.87 (bootstrap 95%CI: US$25.09-US$106.87) lower for those on ART than for those not on ART. The mean total direct non-medical and indirect cost per hospital admission was US$87.84. EQ-5D utility scores were lower amongst HIV-positive participants, but not significantly different between those on and not on ART.\ud \ud Conclusions\ud \ud HIV-related hospital care poses substantial financial burdens on health systems and patients; however, per-admission costs are substantially lower for those already initiated onto ART prior to admission. These potential cost savings could offset some of the additional resources needed to provide universal access to ART.
- Published
- 2018
34. Predictive value of C-reactive protein for tuberculosis, bloodstream infection or death among HIV-infected individuals with chronic, non-specific symptoms and negative sputum smear microscopy
- Author
-
Bedell, Richard A, van Lettow, Monique, Meaney, Christopher, Corbett, Elizabeth L, Chan, Adrienne K, Heyderman, Robert S, Anderson, Suzanne T, Åkesson, Ann, Kumwenda, Moses, Zachariah, Rony, Harries, Anthony D, and Ramsay, Andrew R
- Abstract
BACKGROUND: C-reactive protein (CRP) is an inflammatory biomarker that may identify patients at risk of infections or death. Mortality among HIV-infected persons commencing antiretroviral therapy (ART) is often attributed to tuberculosis (TB) or bloodstream infections (BSI). METHODS: In two district hospitals in southern Malawi, we recruited HIV-infected adults with one or more unexplained symptoms present for at least one month (weight loss, fever or diarrhoea) and negative expectorated sputum microscopy for TB. CRP determination for 452 of 469 (96%) participants at study enrolment was analysed for associations with TB, BSI or death to 120 days post-enrolment. RESULTS: Baseline CRP was significantly elevated among patients with confirmed or probable TB (52), BSI (50) or death (60) compared to those with no identified infection who survived at least 120 days (269). A CRP value of >10 mg/L was associated with confirmed or probable TB (adjusted odds ratio 5.7; 95% CI 2.6, 14.3; 87% sensitivity) or death by 30 days (adjusted odds ratio 9.2; 95% CI 2.2, 55.1; 88% sensitivity). CRP was independently associated with TB, BSI or death, but the prediction of these endpoints was enhanced by including haemoglobin (all outcomes), CD4 count (BSI, death) and whether ART was started (death) in logistic regression models. CONCLUSION: High CRP at the time of ART initiation is associated with TB, BSI and early mortality and so has potential utility for stratifying patients for intensified clinical and laboratory investigation and follow-up. They may also be considered for empirical treatment of opportunistic infections including TB.
- Published
- 2018
35. The Role of Human Immunodeficiency Virus-Associated Vasculopathy in the Etiology of Stroke
- Author
-
Benjamin, Laura A, Allain, Theresa J, Mzinganjira, Henry, Connor, Myles D, Smith, Colin, Lucas, Sebastian, Joekes, Elizabeth, Kampondeni, Sam, Chetcuti, Karen, Turnbull, Ian, Hopkins, Mark, Kamiza, Steve, Corbett, Elizabeth L, Heyderman, Robert S, and Solomon, Tom
- Subjects
Adult ,Male ,Vasculitis ,Malawi ,Anti-HIV Agents ,HIV ,HIV Infections ,Middle Aged ,Viral Load ,CD4 Lymphocyte Count ,Stroke ,Immune Reconstitution Inflammatory Syndrome ,Risk Factors ,Antiretroviral Therapy, Highly Active ,Case-Control Studies ,Journal Article ,Humans ,Female ,Prospective Studies ,Aged - Abstract
Background: Human immunodeficiency virus (HIV) infection is a recognized risk factor for stroke among young populations, but the exact mechanisms are poorly understood. We studied the clinical, radiologic, and histologic features of HIV-related ischemic stroke to gain insight into the disease mechanisms.Methods: We conducted a prospective, in-depth analysis of adult ischemic stroke patients presenting to Queen Elizabeth Central Hospital, Blantyre, Malawi, in 2011.Results: We recruited 64 HIV-infected and 107 HIV-uninfected patients. Those with HIV were significantly younger (P < .001) and less likely to have established vascular risk factors. Patients with HIV were more likely to have large artery disease (21% vs 10%; P < .001). The commonest etiology was HIV-associated vasculopathy (24 [38%]), followed by opportunistic infections (16 [25%]). Sixteen of 64 (25%) had a stroke soon after starting antiretroviral therapy (ART), suggesting an immune reconstitution-like syndrome. In this group, CD4+ T-lymphocyte count was low, despite a significantly lower HIV viral load in those recently started on treatment (P < .001).Conclusions: HIV-associated vasculopathy and opportunistic infections are common causes of HIV-related ischemic stroke. Furthermore, subtypes of HIV-associated vasculopathy may manifest as a result of an immune reconstitution-like syndrome after starting ART. A better understanding of this mechanism may point toward new treatments.
- Published
- 2017
36. Urinary Lipoarabinomannan Detection and Disseminated Nontuberculous Mycobacterial Disease
- Author
-
Gupta-Wright, Ankur, Kerkhoff, Andrew D, Meintjes, Graeme, and Corbett, Elizabeth L
- Published
- 2017
37. Economic Costs and Health-Related Quality of Life Outcomes of HIV Treatment After Self- and Facility-Based HIV Testing in a Cluster Randomized Trial
- Author
-
Maheswaran, Hendramoorthy, Petrou, Stavros, MacPherson, Peter, Kumwenda, Felistas, Lalloo, David G, Corbett, Elizabeth L, and Clarke, Aileen
- Subjects
Adult ,Counseling ,Male ,Malawi ,Adolescent ,HIV self-testing ,EQ-5D ,HIV ,costs ,HIV Infections ,Health Care Costs ,Medication Adherence ,health-related quality of life ,Diagnostic Self Evaluation ,Young Adult ,ComputingMethodologies_DOCUMENTANDTEXTPROCESSING ,Quality of Life ,Cluster Analysis ,Humans ,Mass Screening ,Female ,Health Facilities ,Prospective Studies ,ART ,Implementation Science - Abstract
Supplemental Digital Content is Available in the Text., Background: The scale-up of HIV self-testing (HIVST) in Africa is recommended, but little is known about how this novel approach influences economic outcomes following subsequent antiretroviral treatment (ART) compared with established facility-based HIV testing and counseling (HTC) approaches. Setting: HIV clinics in Blantyre, Malawi. Methods: Consecutive HIV-positive participants, diagnosed by HIVST or facility-based HTC as part of a community cluster-randomized trial (ISRCTN02004005), were followed from initial assessment for ART until 1-year postinitiation. Healthcare resource use was prospectively measured, and primary costing studies undertaken to estimate total health provider costs. Participants were interviewed to establish direct nonmedical and indirect costs over the first year of ART. Costs were adjusted to 2014 US$ and INT$. Health-related quality of life was measured using the EuroQol EQ-5D at each clinic visit. Multivariable analyses estimated predictors of economic outcomes. Results: Of 325 participants attending HIV clinics for assessment for ART, 265 were identified through facility-based HTC, and 60 through HIVST; 168/265 (69.2%) and 36/60 (60.0%), respectively, met national ART eligibility criteria and initiated treatment. The mean total health provider assessment costs for ART initiation were US$22.79 (SE: 0.56) and US$19.92 (SE: 0.77) for facility-based HTC and HIVST participants, respectively, and was US$2.87 (bootstrap 95% CI: US$1.01 to US$4.73) lower for the HIVST group. The mean total health provider costs for the first year of ART were US$168.65 (SE: 2.02) and US$164.66 (SE: 4.21) for facility-based HTC and HIVST participants, respectively, and comparable between the 2 groups (bootstrap 95% CI: −US$12.38 to US$4.39). EQ-5D utility scores immediately before and one year after ART initiation were comparable between the 2 groups. EQ-5D utility scores 1 year after ART initiation had increased by 0.129 (SE: 0.011) and 0.139 (SE: 0.027) for facility-based HTC and HIVST participants, respectively. Conclusions: Once HIV self-testers are linked into HIV services, their economic outcomes are comparable to those linking to services after facility-based HTC.
- Published
- 2017
38. Sex Differences in Tuberculosis Burden and Notifications in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis
- Author
-
Horton, Katherine C, MacPherson, Peter, Houben, Rein M G J, White, Richard G, and Corbett, Elizabeth L
- Subjects
wa_30 ,lcsh:R ,wf_220 ,lcsh:Medicine ,wa_309 ,wf_200 ,wa_300 - Abstract
BACKGROUND\ud Tuberculosis (TB) case notification rates are usually higher in men than in women, but notification data are insufficient to measure sex differences in disease burden. This review set out to systematically investigate whether sex ratios in case notifications reflect differences in disease prevalence and to identify gaps in access to and/or utilisation of diagnostic services.\ud \ud METHODS AND FINDINGS\ud In accordance with the published protocol (CRD42015022163), TB prevalence surveys in nationally representative and sub-national adult populations (age ≥ 15 y) in low- and middle-income countries published between 1 January 1993 and 15 March 2016 were identified through searches of PubMed, Embase, Global Health, and the Cochrane Database of Systematic Reviews; review of abstracts; and correspondence with the World Health Organization. Random-effects meta-analyses examined male-to-female (M:F) ratios in TB prevalence and prevalence-to-notification (P:N) ratios for smear-positive TB. Meta-regression was done to identify factors associated with higher M:F ratios in prevalence and higher P:N ratios. Eighty-three publications describing 88 surveys with over 3.1 million participants in 28 countries were identified (36 surveys in Africa, three in the Americas, four in the Eastern Mediterranean, 28 in South-East Asia and 17 in the Western Pacific). Fifty-six surveys reported in 53 publications were included in quantitative analyses. Overall random-effects weighted M:F prevalence ratios were 2.21 (95% CI 1.92-2.54; 56 surveys) for bacteriologically positive TB and 2.51 (95% CI 2.07-3.04; 40 surveys) for smear-positive TB. M:F prevalence ratios were highest in South-East Asia and in surveys that did not require self-report of signs/symptoms in initial screening procedures. The summary random-effects weighted M:F ratio for P:N ratios was 1.55 (95% CI 1.25-1.91; 34 surveys). We intended to stratify the analyses by age, HIV status, and rural or urban setting; however, few studies reported such data.\ud \ud CONCLUSIONS\ud TB prevalence is significantly higher among men than women in low- and middle-income countries, with strong evidence that men are disadvantaged in seeking and/or accessing TB care in many settings. Global strategies and national TB programmes should recognise men as an underserved high-risk group and improve men's access to diagnostic and screening services to reduce the overall burden of TB more effectively and ensure gender equity in TB care.
- Published
- 2016
39. Arterial ischemic stroke in HIV:Defining and classifying etiology for research studies
- Author
-
Benjamin, Laura A, Bryer, Alan, Lucas, Sebastian, Stanley, Alan, Allain, Theresa J, Joekes, Elizabeth, Emsley, Hedley, Turnbull, Ian, Downey, Colin, Toh, Cheng-Hock, Brown, Kevin, Brown, David, Ison, Catherine, Smith, Colin, Corbett, Elizabeth L, Nath, Avindra, Heyderman, Robert S, Connor, Myles D, and Solomon, Tom
- Subjects
virus diseases - Abstract
HIV infection, and potentially its treatment, increases the risk of an arterial ischemic stroke. Multiple etiologies and lack of clear case definitions inhibit progress in this field. Several etiologies, many treatable, are relevant to HIV-related stroke. To fully understand the mechanisms and the terminology used, a robust classification algorithm to help ascribe the various etiologies is needed. This consensus paper considers the strengths and limitations of current case definitions in the context of HIV infection. The case definitions for the major etiologies in HIV-related strokes were refined (e.g., varicella zoster vasculopathy and antiphospholipid syndrome) and in some instances new case definitions were described (e.g., HIV-associated vasculopathy). These case definitions provided a framework for an algorithm to help assign a final diagnosis, and help classify the subtypes of HIV etiology in ischemic stroke.
- Published
- 2016
40. Arterial ischemic stroke in HIV
- Author
-
Benjamin, Laura A., Bryer, Alan, Lucas, Sebastian, Stanley, Alan, Allain, Theresa J., Joekes, Elizabeth, Emsley, Hedley, Turnbull, Ian, Downey, Colin, Toh, Cheng-Hock, Brown, Kevin, Brown, David, Ison, Catherine, Smith, Colin, Corbett, Elizabeth L., Nath, Avindra, Heyderman, Robert S., Connor, Myles D., and Solomon, Tom
- Subjects
Views & Reviews ,virus diseases - Abstract
HIV infection, and potentially its treatment, increases the risk of an arterial ischemic stroke. Multiple etiologies and lack of clear case definitions inhibit progress in this field. Several etiologies, many treatable, are relevant to HIV-related stroke. To fully understand the mechanisms and the terminology used, a robust classification algorithm to help ascribe the various etiologies is needed. This consensus paper considers the strengths and limitations of current case definitions in the context of HIV infection. The case definitions for the major etiologies in HIV-related strokes were refined (e.g., varicella zoster vasculopathy and antiphospholipid syndrome) and in some instances new case definitions were described (e.g., HIV-associated vasculopathy). These case definitions provided a framework for an algorithm to help assign a final diagnosis, and help classify the subtypes of HIV etiology in ischemic stroke.
- Published
- 2016
41. Rapid urine-based screening for tuberculosis to reduce AIDS-related mortality in hospitalized patients in Africa (the STAMP trial): study protocol for a randomised controlled trial
- Author
-
Gupta-Wright, Ankur, Fielding, Katherine L., van Oosterhout, Joep J., Wilson, Douglas K., Corbett, Elizabeth L., Flach, Clare, Reddy, Krishna P., Walensky, Rochelle P., Peters, Jurgens A., Alufandika-Moyo, Melanie, Lawn, Stephen D., Desmond Tutu HIV Centre, and Faculty of Health Sciences
- Subjects
Adult ,Acquired Immunodeficiency Syndrome ,Malawi ,HIV-associated TB ,AIDS-Related Opportunistic Infections ,Sputum ,HIV ,HIV Infections ,LAM ,Hospitalization ,South Africa ,Infectious Diseases ,TB ,Screening ,Isoniazid ,Humans ,Mass Screening ,Xpert ,Randomized Controlled Trials as Topic - Abstract
BACKGROUND: HIV-associated tuberculosis (TB) co-infection remains an enormous burden to international public health. Post-mortem studies have highlighted the high proportion of HIV-positive adults admitted to hospital with TB. Determine TB-LAM and Xpert MTB/RIF assays can substantially increase diagnostic yield of TB within one day of hospital admission. However, it remains unclear if this approach can impact clinical outcomes. The STAMP trial aims to test the hypothesis that the implementation a urine-based screening strategy for TB can reduce all cause-mortality among HIV-positive patients admitted to hospital when compared to current, sputum-based screening.METHODS: The trial is a pragmatic, individually randomised, multi-country (Malawi and South Africa) clinical trial with two study arms (1:1 recruitment). Unselected HIV-positive patients admitted to medical wards, irrespective of presentation, meeting the inclusion criteria and giving consent will be randomized to screening for TB using either: (i) 'standard of care'- testing of sputum using the Xpert MTB/RIF assay (Xpert) or (ii) 'intervention'- testing of sputum using Xpert and testing of urine using (a) Determine TB-LAM lateral-flow assay and (b) Xpert following concentration of urine by centrifugation. Patients will be excluded if they have received TB treatment in the previous 12 months, if they have received isoniazid preventive therapy in the last 6 months, if they are aged DISCUSSION: This pragmatic trial assesses an intervention to reduce the high mortality caused by HIV-associated TB, which could feasibly be scaled up in high-burden settings if shown to be efficacious and cost-effective. We discuss the challenges of designing a trial to assess the impact on mortality of laboratory-based TB screening interventions given frequent initiation of empirical treatment and a failure of several previous clinical trials to demonstrate an impact on clinical outcomes. We also elaborate on the practical and ethical issues of 'testing a test' in general.TRIAL REGISTRATION: ISRCTN Registry ( ISRCTN71603869 ) prospectively registered 08 May 2015; the South African National Controlled Trials Registry (DOH-27-1015-5185) prospectively registered October 2015.
- Published
- 2016
- Full Text
- View/download PDF
42. Treatment-Seeking for Tuberculosis-Suggestive Symptoms: A Reflection on the Role of Human Agency in the Context of Universal Health Coverage in Malawi
- Author
-
Kumwenda, Moses, Desmond, Nicola, Hart, Graham, Choko, Augustine, Chipungu, Geoffrey A., Nyirenda, Deborah, Shand, Tim, Corbett, Elizabeth L., Chikovore, Jeremiah, Department of Public Health and Family Medicine, and Faculty of Health Sciences
- Subjects
Bacterial Diseases ,Male ,Malawi ,Fever ,Physiology ,Health Personnel ,Health Behavior ,lcsh:Medicine ,Pathology and Laboratory Medicine ,Drug interactions ,26bc6fb8 ,Geographical Locations ,Antimalarials ,Signs and Symptoms ,Medicine and Health Sciences ,Coughing ,Humans ,Tuberculosis ,Tuberculosis diagnosis and management ,Community Health Services ,Health care providers ,lcsh:Science ,f0e481db ,Pharmacology ,Masculinity ,Fluorenes ,Artemether, Lumefantrine Drug Combination ,lcsh:R ,Biology and Life Sciences ,Health care facilities ,HIV diagnosis and management ,Focus Groups ,Patient Acceptance of Health Care ,Tropical Diseases ,Diagnostic medicine ,Artemisinins ,Health Care ,Drug Combinations ,Infectious Diseases ,Cough ,Ethanolamines ,People and Places ,Africa ,Chronic Disease ,wf_220 ,Female ,lcsh:Q ,Physiological Processes ,Research Article - Abstract
Tuberculosis (TB) is highly infectious and one of the leading killers globally. Several studies from sub-Saharan Africa highlight health systems challenges that affect ability to cope with existing disease burden, including TB, although most of these employ survey-type approaches. Consequently, few address community or patient perspectives and experiences. At the same time, understanding of the mechanisms by which the health systems challenges translate into seeking or avoidance of formal health care remains limited. This paper applies the notion of human agency to examine the ways people who have symptoms suggestive of TB respond to and deal with the symptoms vis-à-vis major challenges inherent within health delivery systems. Empirical data were drawn from a qualitative study exploring the ways in which notions of masculinity affect engagement with care, including men’s well-documented tendency to delay in seeking care for TB symptoms. The study was carried out in three high-density locales of urban Blantyre, Malawi. Data were collected in March 2011 –March 2012 using focus group discussions, of which eight (mixed sex = two; female only = three; male only = three) were with 74 ordinary community members, and two (both mixed sex) were with 20 health workers; and in-depth interviews with 20 TB patients (female = 14) and 20 un-investigated chronic coughers (female = eight). The research process employed a modified version of grounded theory. Data were coded using a coding scheme that was initially generated from the study aims and subsequently progressively amended to incorporate concepts emerging during the analysis. Coded data were retrieved, re-read, and broken down and reconnected iteratively to generate themes. A myriad of problems were described for health systems at the primary health care level, centring largely on shortages of resources (human, equipment, and drugs) and unprofessional conduct by health care providers. Participants consistently pointed out how the problems could drive patients from promptly reporting symptoms at primary healthcare centres. The accounts suggest that in responding to illness symptoms including those suggestive of TB, patients navigate their options taking into cognisance past and current experiences with formal health systems. Understanding and factoring in the mediating role of such ‘agency’ is critical when implementing efforts to promote timely response to TB-suggestive symptoms.
- Published
- 2016
43. Cardiac disease in adolescents with delayed diagnosis of vertically acquired HIV infection
- Author
-
Miller, Robert F, Kaski, Juan P, Hakim, James, Matenga, Jonathan, Nathoo, Kusum, Munyati, Shungu, Desai, Sujal R, Corbett, Elizabeth L, and Ferrand, Rashida A
- Abstract
BACKGROUND: At least one-third of human immunodeficiency virus (HIV)-infected infants survive to adolescence even without antiretroviral therapy (ART), but are at high risk of complications including cardiac disease. We investigated the characteristics of cardiac disease among adolescents with HIV infection diagnosed in late childhood who were receiving ambulatory HIV care in Harare, Zimbabwe. METHODS: Consecutive adolescents with vertically acquired HIV attending 2 HIV outpatient treatment clinics were studied. Assessment included clinical history and examination, and 2-dimensional, M-mode, pulsed- and continuous-wave Doppler echocardiography. RESULTS: Of 110 participants (47% male; median age, 15 years; interquartile range, 12-17 years), 78 (71%) were taking ART. Exertional dyspnea, chest pain, palpitations, and ankle swelling were reported by 47 (43%), 43 (39%), 10 (9%), and 7 (6%), respectively. The New York Heart Association score was ≥ 2 in 41 participants (37%). Echocardiography showed that 74 participants (67%) had left ventricular (LV; septal and/or free wall) hypertrophy and 27 (24%) had evidence of impaired LV relaxation or restrictive LV physiology. The estimated pulmonary artery systolic pressure (ePASP) was >30 mm Hg in 4 participants (3.6%); of these 2 also had right ventricular (RV) dilatation. Another 32 participants (29%), without elevated ePASP, had isolated RV dilatation. CONCLUSIONS: A significant burden of cardiac disease was seen among adolescents with vertically acquired HIV infection. More than half were asymptomatic yet had significant echocardiographic abnormalities. These findings highlight the need to screen this population in order to better define the geography, natural history, etiopathogenic mechanisms, and management (including the timing and choice of optimal therapeutic ART and cardiac drug interventions) to prevent development and/or progression of HIV-associated cardiac disease.
- Published
- 2013
44. Chronic lung disease in adolescents with delayed diagnosis of vertically acquired HIV infection
- Author
-
Ferrand, Rashida A, Desai, Sujal R, Hopkins, Charlotte, Elston, Caroline M, Copley, Susan J, Nathoo, Kusum, Ndhlovu, Chiratidzo E, Munyati, Shungu, Barker, Richard D, Miller, Robert F, Bandason, Tsitsi, Wells, Athol U, and Corbett, Elizabeth L
- Abstract
BACKGROUND: Long-term survivors of vertically acquired human immunodeficiency virus (HIV) infection are reaching adolescence in large numbers in Africa and are at high risk of delayed diagnosis and chronic complications of untreated HIV infection. Chronic respiratory symptoms are more common than would be anticipated based on the HIV literature. METHODS: Consecutive adolescents with presumed vertically acquired HIV attending 2 HIV care clinics in Harare, Zimbabwe, were recruited and assessed with clinical history and examination, CD4 count, pulmonary function tests, Doppler echocardiography, and chest radiography (CXR). Those with suspected nontuberculous chronic lung disease (CLD) were scanned using high-resolution computed tomography (HRCT). RESULTS: Of 116 participants (43% male; mean age, 14 ± 2.6 years, mean age at HIV diagnosis, 12 years), 69% were receiving antiretroviral therapy. Chronic cough and reduced exercise tolerance were reported by 66% and 21% of participants, respectively; 41% reported multiple respiratory tract infections in the previous year, and 10% were clubbed. More than 40% had hypoxemia at rest (13%) or on exercise (29%), with pulmonary hypertension (mean pulmonary artery pressure >25 mm Hg) in 7%. Forced expiratory volume in 1 second (FEV(1)) was 40% of unselected adolescent clinic attendees meeting criteria for severe hypoxic CLD. This condition is not obvious at rest. Etiology, prognosis, and response to treatment are currently unknown.
- Published
- 2012
45. A primary care level algorithm for identifying HIV-infected adolescents in populations at high risk through mother-to-child transmission
- Author
-
Ferrand, Rashida A, Weiss, Helen A, Nathoo, Kusum, Ndhlovu, Chiratidzo E, Mungofa, Stanley, Munyati, Shungu, Bandason, Tsitsi, Gibb, Diana M, and Corbett, Elizabeth L
- Subjects
Male ,Zimbabwe ,Primary Health Care ,Adolescent ,mother-to-child transmission ,HIV ,HIV Infections ,Infectious Disease Transmission, Vertical ,HIV/AIDS ,Humans ,Female ,Child ,Epidemiologic Methods ,Algorithms - Abstract
OBJECTIVE: To present an algorithm for primary-care health workers for identifying HIV-infected adolescents in populations at high risk through mother-to-child transmission. METHODS: Five hundred and six adolescent (10-18 years) attendees to two primary care clinics in Harare, Zimbabwe, were recruited. A randomly extracted 'training' data set (n = 251) was used to generate an algorithm using variables identified as associated with HIV through multivariable logistic regression. Performance characteristics of the algorithm were evaluated in the remaining ('test') records (n = 255) at different HIV prevalence rates. RESULTS: HIV prevalence was 17%, and infection was independently associated with client-reported orphanhood, past hospitalization, skin problems, presenting with sexually transmitted infection and poor functional ability. Classifying adolescents as requiring HIV testing if they reported >1 of these five criteria had 74% sensitivity and 80% specificity for HIV, with the algorithm correctly predicting the HIV status of 79% of participants. In low-HIV-prevalence settings (
- Published
- 2011
46. HIV decline due to reductions in risky sex in Zimbabwe? Evidence from a comprehensive epidemiological review
- Author
-
Gregson, Simon, Gonese, Elizabeth, Hallett, Timothy, Taruberekera, Noah, Hargrove, John W, Lopman, Ben, Corbett, Elizabeth L, Department of Infectious Disease Epidemiology [London] (DIDE), Imperial College London, Zimbabwe Ministry of Health and Child Welfare, Population Services International, Population Services International [Washington], ZVITAMBO Project, and London School of Hygiene and Tropical Medicine (LSHTM)
- Subjects
Medicine - Abstract
International audience; Background Recent data from ANC surveillance and general population surveys suggest substantial declines in HIV prevalence in Zimbabwe. We assessed the contributions of rising mortality, falling HIV incidence and sexual behaviour change to the decline in HIV prevalence. Methods Comprehensive review and secondary analysis of national and local sources on trends in HIV prevalence, HIV incidence, mortality and sexual behaviour covering the period 1985 to 2007. Results HIV prevalence fell in Zimbabwe over the past decade (national estimates: 29.3%, 1997 to 15.6%, 2007). National Census and survey estimates, vital registration data from Harare and Bulawayo, and prospective local population survey data from eastern Zimbabwe showed substantial rises in mortality during the 1990s levelling off after 2000. Direct estimates of HIV incidence in male factory workers and women attending pre- and post-natal clinics, trends in HIV prevalence in 15-24 year-olds, and back-calculation estimates based on the vital registration data from Harare indicated that HIV incidence may have peaked in the early 1990s and fallen during the 1990s. Household survey data showed reductions in numbers reporting casual partners from the late 1990s and high condom use in non-regular partnerships between 1998 and 2007. Conclusions These findings provide the first convincing evidence of an HIV decline accelerated by changes in sexual behaviour in a southern African country. However, in 2007, one in every seven adults in Zimbabwe was still infected with a life-threatening virus and mortality rates remained at crisis-levels.
- Published
- 2010
47. Prevalent infectious tuberculosis in Harare, Zimbabwe: burden, risk factors and implications for control
- Author
-
Corbett, Elizabeth L, Bandason, Tsitsi, Cheung, Yin Bun, Makamure, Beauty, Dauya, Ethel, Munyati, Shungu S, Churchyard, Gavin J, Williams, Brian G, Butterworth, Anthony E, Mungofa, Stanley, Hayes, Richard J, and Mason, Peter R
- Subjects
Adult ,Male ,Zimbabwe ,Adolescent ,HIV Infections ,Middle Aged ,Article ,Young Adult ,Sex Factors ,Cost of Illness ,Residence Characteristics ,Risk Factors ,Communicable Disease Control ,Humans ,Mass Screening ,Tuberculosis ,Female - Abstract
Harare's high density suburbs.To investigate the burden, duration and risk factors for prevalent tuberculosis (TB) and explore potential control strategies.Randomly selected adults had TB culture, symptom screen and human immunodeficiency virus (HIV) serology. Prevalent TB was defined as undiagnosed or still culture-positive. Notification data and HIV prevalence in TB out-patients were used to estimate duration of infectiousness (prevalence/estimated incidence).Among 10 092 participants, 40 (0.40%, 95%CI 0.28-0.54) had prevalent smear-positive TB. HIV (adjusted odds ratio [aOR] 3.1, 95%CI 1.6-6.3, population attributable fraction [PAF] 33%), male sex (aOR 3.1, 95%CI 1.5-6.4, PAF 40%), and overcrowding (PAF 34%) were significant risk factors, with past TB treatment significant for HIV-negative participants only (PAF 7%). Recent household TB contact was not significant (PAF 10%). HIV prevalence was 21.1%; 76.9% of HIV-positive participants were previously untested. Duration of infectiousness was at least 18 weeks in HIV-positive and approximately 1 year in HIV-negative patients.Overcrowding, male sex and HIV infection were major risk factors for prevalent smear-positive TB. Reducing diagnostic delay may have greater potential to improve the control of prevalent TB than interventions targeted at household contacts, TB treatment outcomes, or TB-HIV interventions under current levels of awareness of HIV status.
- Published
- 2009
48. Mycobacterium Tuberculosis Blood Stream Infection Prevalence, Diagnosis, and Mortality Hazard in HIV-Positive Adults: A Systematic Review and Meta-Analysis of Individual Patient Data
- Author
-
Barr, David A, Lewis, Joseph M, Feasey, Nicholas, Schutz, Charlotte, Kerkhoff, Andrew D, Jacob, Shevin T, Andrews, Ben, Kelly, Paul, Lakhi, Shabir, Muchemwa, Levy, Bacha, Helio A, Hadad, David J, Bedell, Richard, van Lettow, Monique, Zachariah, Rony, Crump, John A, Alland, David, Corbett, Elizabeth L, Gopinath, Krishnamoorthy, Singh, Sarman, Griesel, Rulan, Maartens, Gary, Mendelson, Marc, Ward, Amy, Parry, Christopher M, Talbot, Elizabeth A, Munseri, Patricia, Dorman, Susan E, Martinson, Neil, Shah, Maunank, Cain, Kevin, Heilig, Charles M, Varma, Jay, von Gottberg, Anne, Sacks, Leonard, Wilson, Douglas, Squire, S Bertel, Lalloo, David G, Davies, Geriant R, and Meintjes, Graeme
49. Additional file 1 of Tuberculosis diagnosis cascade in Blantyre, Malawi: a prospective cohort study
- Author
-
Feasey, Helena R. A., Corbett, Elizabeth L., Marriott Nliwasa, Mair, Luke, Divala, Titus H., Wala Kamchedzera, Mc Ewen Khundi, Burchett, Helen E. D., Webb, Emily L., Hendramoorthy Maheswaran, S. Bertel Squire, and MacPherson, Peter
- Subjects
3. Good health - Abstract
Additional file 1 Table S1. Characteristics of adult acute clinic attendances by exit interview participation.
50. Additional file 1 of Tuberculosis diagnosis cascade in Blantyre, Malawi: a prospective cohort study
- Author
-
Feasey, Helena R. A., Corbett, Elizabeth L., Marriott Nliwasa, Mair, Luke, Divala, Titus H., Wala Kamchedzera, Mc Ewen Khundi, Burchett, Helen E. D., Webb, Emily L., Hendramoorthy Maheswaran, S. Bertel Squire, and MacPherson, Peter
- Subjects
3. Good health - Abstract
Additional file 1 Table S1. Characteristics of adult acute clinic attendances by exit interview participation.
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.